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ABSTRACT
In mitochondria, the tricarboxylic acid (TCA) cycle integrates oxidation pathways 
of all major carbon sources by eight enzymes that are associated into a supramolecular 
complex called the metabolon. In metabolons, substrate channeling is the most remarkable 
feature, which is the directed or facilitated intermediate transport between active sites. 
Considerable studies have been done on biological implications of substrate channeling in 
improving coupled catalysis. Nowadays the TCA cycle metabolon attracts increasing 
interest from experts in the field of bioelectrocatalysis, who have been seeking highly 
efficient enzyme cascades enabling deep substrate oxidation and promoted mass transport. 
This dissertation research focuses on the fundamental understanding of the TCA cycle 
metabolon from mechanistic and structural perspectives.
In this work, a microfluidic system was built to study enzyme dynamics in 
metabolon formation and showed that intermediate generated by one enzyme induces 
directed transport of subsequent enzymes against the concentration gradient, and thus 
enhances enzyme association. Structural probing by in vivo cross-linking, mass 
spectrometry and protein docking revealed protein-protein interactions in the natural TCA 
cycle metabolon. Computer simulation demonstrated the formation of an electrostatic 
channeling upon association-induced surface charge rearrangement.
The other aspect of this dissertation is in vitro fabrication of the TCA cycle 
metabolon mimics by two strategies. Polymeric co-immobilization-induced multi-enzyme
aggregation was assessed by acceptor photobleaching FRET imaging. Structure-based 
design of engineered metabolons was also exploited to construct a recombinant complex 
featuring natural orientation and enhanced substrate channeling.
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CHAPTER 1 
INTRODUCTION
1.1 Overview of the Tricarboxylic Acid Cycle 
The tricarboxylic acid cycle (TCA cycle), also named the citric acid cycle or the 
Krebs cycle, is the central pathway integrating the carbon flows originated from all main 
classes of biomolecules and energy conversion in conjunction with oxidative 
phosphorylation.1 It was first postulated by Krebs in 1937. Combining P-oxidation of fatty 
acids, oxidative deamination of amino acids, decarboxylation of a-ketonic acids and 
rearrangement of citrate to succinate, Krebs put forward a scheme of the TCA cycle for 
carbohydrate degradation to carbon dioxide. Although Krebs’ hypothesis received severe 
criticism back then, numerous supporting results, such as discoveries of acetyl coenzyme 
A (CoA) as well as fatty acids and ketones as crucial carbon sources for citrate formation, 
finally led the majority to accept the TCA cycle as the common end point of oxidation 
pathways of most carbohydrates, fatty acids and amino acids. Along with technical 
advancement in biochemistry, extensive work has been conducted toward the enzymes and 
metabolic roles of the TCA cycle, which is widely accepted as one of the most astonishing 
achievements in the realm of metabolism research.2,3
1.1.1 Enzymatic Reactions of the TCA Cycle
Aerobically, most biomolecules (i.e. pyruvate and fatty acids) enter the TCA cycle 
as acetyl-CoA and are sequentially broken down into CO2 through eight steps (Figure 1.1). 
The first step, also the most essential step, is the condensation of oxaloacetate (OAA) and 
aceyl-CoA to citrate, generating CoA as well. This reaction is catalyzed by citrate synthase 
(CS), which is a homodimer (98 kDa) containing two identical active sites for OAA and 
binding sites for acetyl-CoA. During the catalytic cycle, the reaction occurs in an ordered 
manner; that is, OAA binds to CS first to result in a 20-fold increase in binding constant 
for acetyl-CoA. As a key rate-limiting enzyme, CS maintains the cyclic flux by catalyzing 
the only C-C formation in the TCA cycle.4
Via cis-aconitate, citrate is isomerized to isocitrate by a stereospecific dehydration- 
rehydration process at the active site of a monomeric enzyme called aconitase (ACO, 83 
kDa). Being an iron-sulfur protein, ACO can be activated by incorporating another iron (II) 
to turn inactive [3Fe-4S] to active [4Fe-4S], which is then complexed with citrate. 
Substantial proton extraction from carboxyl group of citrate results in formation of a Ca- 
Cp double bond in cis-aconitate. To proceed towards isocitrate, cis-aconitate is rotated by 
180° around the double bond and rehydrated by the previously abstracted proton.5
The first NAD(H)-dependent oxidoreductase in the TCA cycle, isocitrate 
dehydrogenase (ICDH), catalyzes the oxidative decarboxylation of isocitrate to a - 
ketoglutarate and CO2 through a phosphorylation and dephosphorylation cycle of the
2
3Figure 1.1 Metabolic role of the TCA cycle in anaerobic degradation (oxidation).1
enzyme. 1,6
The following a-ketoglutarate dehydrogenase (aKGDH) is a gigantic multi enzyme 
complex consisting of three different enzymes, 2-oxoglutarate decarboxylase (E1k), 
dihydrolipoamide succinyltransferase (E2k) and dihydrolipoamide dehydrogenase. Similar 
to ICDH, the aKGDH complex catalyzes the second oxidative decarboxylation of a- 
ketoglutarate to succinyl-CoA, accompanied by CO2 generation and NAD+ reduction.7
The next enzyme, succinyl-CoA synthetase (SCS), or succinyl thiokinase, contains 
two subunits, a (33.5 kDa) and P (46.5 kDa). It catalyzes the reversible hydrolysis of 
succinyl-CoA to succinate and CoA, and the substrate-level phosphorylation of GDP or 
ADP by phosphate. It is the only step in the cycle that directly produces metabolic energy, 
GTP or ATP, depending on the isoforms of SCS and concentration ratios of nucleotide 
diphosphate to nucleotide triphosphate in mitochondria.8,9
Unlike other soluble TCA cycle enzymes in the matrix, succinate dehydrogenase 
(SDH) is a membrane bound enzyme as Complex II of the respiratory electron transport 
chain (ETC) in the inner mitochondrial membrane.10 At the FAD-containing center of SDH, 
protons are extracted from succinate to form fumarate. Electrons are transferred from 
FADH2 to the final carrier ubiquinone. Fumarate is then catalytically rehydrated by 
fumarase (FUM) to L-malate for the final step of the cycle.11
4
5c 4h 6o 4 + fad  ----- <---- — > c 4h 4o 4 + f a d h 2
The last NAD-dependent oxidoreductase, malate dehydrogenase (MDH) catalyzes 
the final oxidation (dehydrogenation) of L-malate reversibly back to oxaloacetate (OAA). 
MDH is also a homodimer (70 kDa) and highly stereospecific to L-malate. D-malate can 
occupy the MDH active site, but will not be converted, thus working as an inhibitor of 
MDH. It is worth mentioning that MDH has two structural forms: mitochondrial form 
(mMDH) and cytoplasmic form (cMDH). The two forms play a very important part in the 
ATP production chain. Since NADH cannot directly pass through the mitochondrial 
membrane from the cytoplasm, cMDH catalyzes its oxidation to NAD+ with reduction of 
OAA to L-malate, which is shuttled through the membrane into the mitochondrial matrix.12 
There mMDH catalyzes the reverse reaction, and regenerated NADH is thus used to pump 
up the ETC for ATP production.
1.1.2 Metabolic Roles of the TCA Cycle
The TCA cycle occupies the central hub in the energy supply for cellular activities 
by connecting glycolysis in the mitochondrial matrix and ETC in the inner membrane o f 
mitochondria. As the major carbon and energy sources for most organisms, hexoses are 
degraded by the glycolysis pathway to pyruvate, which is subsequently converted to acetyl- 
CoA under the catalysis of pyruvate dehydrogenase complex (PDH complex), or to OAA 
under the catalysis of pyruvate carboxylase. Both of the products are utilized by CS in the
first step of the TCA cycle and finally completely oxidized to CO2. Meanwhile, NADH is 
produced for the ETC to pump a proton gradient across the mitochondrial membrane, and 
ultimately power ATP synthetase. For each unit of hexose, such as glucose, a total of 38 
ATP and 6 CO2 molecules are generated from glycolysis, the PDH complex, the TCA cycle 
and the ETC.
Besides carbohydrates, fatty acids and amino acids can also be converted into 
metabolic energy by aerobic oxidation. From one unit of fatty acids, such as stearic acid, 9 
acetyl-CoA molecules enter the TCA cycle after P-oxidation, followed by complete 
oxidation to 18 CO2 molecules and generation of 108 ATP in total together with the ETC. 
In the case of using amino acids as energy sources, the situation is more complex as there 
are several different entrances to the TCA cycle based on the types of amino acids involved. 
For most common amino acids, acetyl-CoA remains the linkage between transamination 
and CS-catalyzed decarboxylation. However, for proline, arginine, histidine and glutamine, 
they are primarily transferred to glutamate, which is oxidized by glutamate dehydrogenase 
to a-ketoglutarate, and taken up by the aKGDH complex. For valine, isoleucine, 
methionine and threonine, they are converted to succinyl-CoA for SCS. For tyrosine and 
phenyalanine, they are converted to fumarate for FUM, while asparagine enters the TCA 
cycle through a series of transformations catalyzed by aspartate aminotransferase (AAT) 
and MDH.
When pushing ATP production from biofuels, the TCA cycle runs its second role 
in the synthesis of a variety of biomaterials, at the expense of ATP. For example, most of 
the amino acids (precursors for protein synthesis) can be regenerated from intermediates 
(isocitrate, a-ketoglutarate, succinyl-CoA, L-malate and oxaloacetate) of the TCA cycle.
6
Similar schemes can be drawn for biosynthesis of lipids and carbohydrates; however, this 
will not be discussed in details as the dissertation focuses on the catabolic role of the TCA 
cycle in complete oxidation and energy production.1,13,14
1.1.3 Regulation of the TCA Cycle
ATP production and consumption in the TCA cycle for metabolic needs are 
primarily regulated by the ratio of NADH/NAD+ in mitochondria. In general, high 
NADH/NAD+ leads to phosphorylation of AMP and ADP to produce more ATP, while 
low NADH/NAD+ initiates ATP hydrolysis in demand of energy. Within the cycle, CS- 
catalyzed acetyl-CoA-OAA condensation and ICDH-catalyzed isocitrate decarboxylation 
are two major regulatory sites. Both ATP and NADH at high concentration levels will place 
negative effects on the activity of CS and ICDH, decreasing the overall oxidation rate. 
Accumulation of ADP/AMP and NAD+ after a burst of energy utilization will activate 
ICDH to speed up ATP production. It is worth noting that the situation for ICDH is more 
complex, since its function is linked to another bifunctional protein kinase/phosphatase, 
and a set of metabolites have been identified as effectors on the ICDH phosphorylation 
cycle.6,15 Other dehydrogenases are also subject to NADH/NAD+ regulation with various 
sensitivities. In addition, the TCA cycle flux is closely associated with substrate supplies 
from auxiliary enzymes in glycolysis, fatty acid oxidation and transamination. Pools of 
intermediates/products generated in each step are very important in coordinating the cycle 
flux, which is known as the feedback mechanism. As an example, citrate is a competitive 
inhibitor for CS as well as for mMDH.13,14,16,17
7
81.2 Metabolic Enzymes as Biocatalysts in Enzymatic Biofuel Cells
1.2.1 Kinetics of Enzymes as Biocatalysts
Enzyme kinetics study time-dependent enzyme-catalyzed reactions approaching 
the equilibrium state. In a simple second-order model as below
Substrate (S) reversibly binds to enzyme (E) to form a transition enzyme-substrate complex 
(ES). ES then proceeds to the formation of product (P) and recovery of E.
Rate of product formation is described by turnover rate v, which is directly 
dependent on concentration of ES as below
d[P] = k2[ES] = vdt
[ES] is determined by
d[S] = k  [S][E] + k-j [ES]
d[E] = -kj [S][E] + (k.j+k2)[ES]
d[ES] = -kj[S][E] -  (k.j+k2)[ES]
During the course of time-dependent changes of S or P illustrated in Figure 1.2, 
there are three phases: a short initial or pre-steady-state phase where ES is formed and v is 
low, a steady-state phase where [ES] is almost constant and v reaches its maximal, and a 
substrate depletion phase where [ES] decays with S exhausted and v decreasing to nearly 
zero. The lengths of the three phases are dependent on ki, k-i and &2. Based on the 
assumption that the steady-state phase is relatively longer than the other two phases (ki ~ 
k-i> ki), the reaction can be regarded as in quasi equilibrium state for a limited period when
9Figure 1.2 Time-dependent changes of substrate ([S]), product ([P]), free enzyme ([E]) and 
bound enzyme ([ES]): (i) pre-steady-state phase, (ii) steady-state phase, (iii) substrate- 
depletion phase.18
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[S] and [P] change linearly to keep [ES] constant. Therefore, it is reasonable to say
ki[S][E] = (k-i + k2)[ES]
Since [E]o = [E] + [ES], then
ki [E] [S][ES] = 1[ ]o[ ]ki[S]+k-i+k2 
and
k2[E]o[S]v = k2[ES] =
ki
By defining Km = (k-i + ki)/ki and Vmax = k2[E]o, the Michaelis-Menten equation is 
achieved as below
Vmax[S]V =  ------------Km + [S]
According to the Michaelis-Menten kinetic theory, [E]o does not change 
considerably during the reaction and all enzyme molecules are accessible for substrate 
binding to achieve the highest possible turnover. It is assumed that the system reaches the 
equilibrium between free enzymes and bound enzymes much faster than the catalytic 
reaction, so the Michaelis constant Km is directly associated to the dissociation constant for 
substrate and enzyme, and indicates the affinity of a specific substrate to the enzyme (the 
lower Km, the higher affinity):
Km = Kd = k-i/ ki
Vmax and kcat = Vmax/[E]o refer to the maximum turnover rate and the turnover number (or 
catalytic constant), respectively. Finally, the catalytic efficiency is defined as the ratio
kcat/Km.19
1.2.2 Enzymatic Biofuel Cell
Enzymatic biofuel cells (BFCs) are fuel cells employing enzymes to catalyze 
energy conversion from different substrates/fuels to electricity. As illustrated in Figure 1.3, 
a typical enzymatic BFC consists of four basic parts: (1) a bioanode where oxidoreductases 
catalyze oxidation of fuels and extract electrons to the electrode directly or through 
mediators, (2) a cathode (frequently biocathode) where the oxidant (i.e. O2) is catalytically 
reduced to accomplish electrical work, (3) an external circuit to transport electrons from 
anode to cathode, and (4) electrolyte to support ion movement between electrodes. 
Compared to conventional fuel cells, enzymatic BFCs do not require toxic or costly 
fabrication. By utilizing renewable fuel sources, they are capable of producing sustainable 
energy and functioning at mild conditions. Therefore, enzymatic BFCs give a promising 
future in micro-power sources (i.e. blood glucose sensors, pacemakers, blood pressure or 
hormone monitors) fueled by biomass or in vivo body fluid.20-22
1.2.3 Metabolic Enzyme Cascades in Enzymatic Biofuel Cells
Because of the high substrate selectivity of single enzymes, enzyme cascades are 
now under frequent investigation to catalyze deep oxidation of high energy density fuels 
(alcohols, glycerol, etc.). To improve the coulombic efficiency of a glucose BFC, Tasca et 
al. developed a bioanode with combined pyranose and cellobiose dehydrogenases to 
extract up to six electrons from one glucose molecule, compared to traditional glucose 
BFCs yielding only two electrons per glucose molecule. 23 Lang et al. designed an 
enzymatic BFC capable of producing a maximum power density at 8 ^W/cm2 out of starch 
by co-immobilizing glucoamylase and glucose oxidase on a bioanode.24 Palmore et al. 
fabricated a methanol/O2 BFC to achieve the complete breakdown of methanol to CO2
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Figure 1.3 Schematic of an enzymatic glucose BFC. Glucose oxidase (PDB ID: 1GPE) 
catalyzes oxidation o f glucose to gluconolactone at the anode and laccase (PDB ID: 2XU9) 
catalyzes oxidation of O2 to H2O at the cathode.
through an enzyme cascade consisting of NAD+-dependent alcohol, aldehyde and formate 
dehydrogenases together with diapharose as the electrocatalyst for NADH oxidation. Neto 
et al. used a two-enzyme cascade of PQQ-dependent alcohol and aldehyde dehydrogenases 
to oxidize ethanol to acetate through direct electron transfer (higher electrode coupling 
efficiency than mediated electron transfer when NAD+-dependent dehydrogenases are used) 
to the anode.25 Arechederra et al. developed a three-enzyme cascade combining PQQ- 
dependent alcohol dehydrogenase, PQQ-dependent aldehyde dehydrogenase and an 
additional oxalate oxidase to completely oxidize glycerol.26,27 Furthermore, Xu et al. 
designed a six-enzyme cascade immobilized bioanode to sequentially oxidize glucose to 
CO2 in an artificial, minimal metabolic pathway.28
1.2.4 Application of the TCA Cycle in Enzymatic Biofuel Cells
Due to its central place in the network of metabolism of sugars, lipids and amino 
acids, the TCA cycle has been extensively studied to understand mitochondrion-related 
signaling pathways, metabolic disorders and tumorigenesis under physiological and 
pathological conditions.2 In recent years, researchers came to recognize its potential 
application in enzymatic BFCs.29 Sokic-Lazic et al. reconstituted the TCA cycle from 
commercially purified enzymes and coupled it to lactate dehydrogenase or pyruvate 
dehydrogenase to oxidize lactate or pyruvate. This proved to be dramatically more efficient 
than single enzyme BFCs as both current and power densities were increased by at least 20 
folds .30,31 Fukuda et al. incorporated the TCA cycle into a microenzymatic electrolysis cell 
and electrochemically characterized the metabolic regulation on an electrode. Their 
fundamental study further confirmed the capability o f TCA-cycle-based systems for 
harnessing electric energy out of organic acids.32 Reconstruction of the coupled cycle in
13
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vitro will definitely expand its application in the new-generation devices powered by a 
wide range of fuels.
1.3 Metabolon and Substrate Channeling Formation
Bringing multiple enzymes together also raises new challenges. Mass transport
issue remains one of the main hurdles that limit the performance of enzymatic BFCs. For
a two-enzyme-cascade-modified bioanode which extracts n electrons at the second enzyme,
current (i) is in direct proportion to turnover rates of the two reactions (kcati and kcat2) and
inverse proportion to time (t) for intermediate diffusing.33
ni a
1 + 1 + 1kcati kcat2
Normally, intermediates tend to equilibrate with the bulk solution before they reach 
the next active site. Increased diffusion time lowers the coupled energy conversion rate and 
the current density, but this problem is intelligently solved in vivo. Nature has found its 
way to boost mass transport between enzymes within cells, where the environment is 
technically harsher for efficient transport of small molecules through highly crowded 
pathways full of obstacles like polysaccharides, proteins and nucleic acids. Rather than 
diffusing freely and randomly in the cytoplasm, sequential metabolic enzymes are spatially 
organized into three-dimensional supramolecular complexes, which were first named 
metabolons by Paul. A. Srere 30 years ago. This definitely changed people’s view of the 
cell as “a bag of enzymes” in early times, because metabolons were found to exist in almost 
all metabolic pathways and cells. 34-36
1.3.1 Metabolon Formation
Metabolons are multienzyme complexes formed through various interactions 
including covalent linkages, electrostatic forces, hydrophobic interactions, hydrogen 
bonding and Van der Waals interactions. Based on their robustness, metabolons can be 
generally classified into static and dynamic complexes.35,37 Static complexes are tightly 
associated through stronger interactions and more resistant to environmental alterations. 
Therefore, they are isolatable. For example, the PDH complex and the aKGDH complex 
are static complexes. On the contrary, dynamic complexes are held together by much 
weaker forces. This type of metabolons are usually observed in highly progressive 
pathways with numerous metabolic crossroads, such as the glycolytic pathway and the 
TCA cycle. Transient association allows their quick reorganization in response to any 
external stimuli. In these complexes, intermediates are not always strongly bound as in 
static complexes but locally accumulated around metabolons to form discrete “pools”, 
which is in fact a wise strategy to overcome limited solvation in cells. It also facilitates the 
preferential delivery of intermediates for specific products and control of metabolic 
flux.35,38,39 Although the mechanism for metabolon formation is not fully understood, it is 
believed that the unique cellular community supported by structural scaffolds (filament and 
microtubule) is essential in stabilizing dynamic complexes. In the living cells, proteins are 
highly concentrated. The aqueous phase is highly viscous as half of water molecules are in 
the bound state, and 30% of space is occupied by macromolecules. This so-called volume- 
excluding effect promotes not only protein-protein interactions but also protein-scaffold 
interactions, resulting in compartmentalization of metabolic pathways.35,40,41 In the 
meantime, small metabolites may also place a nonnegligible effect on the stability of these
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loosely associated complexes.42 Therefore, membrane disruption and protein dilution 
during isolation and purification often lead to instant dissociation of dynamic metabolons.
1.3.2 Isolation of Dynamic Metabolons
Compared to stable multifunctional proteins or multienzyme complexes, dynamic 
metabolons always require special attention to minimize or overcome adverse effects 
during isolation. First of all, relatively gentle cell disruption is needed to recover enzyme 
associations. Second, dilution factors can be compensated by adding in volume-excluding 
agents like polyethylene glycol (PEG) or accumulating proteins in ammonium sulfate- 
induced precipitation. Third, metabolic enzymes should be co-fractionated during each 
isolation step. Finally, protein-protein interactions (not random aggregation) are conserved 
after isolation.42 Despite the technical difficulties, a number of metabolons have been 
isolated from nucleic acid biosynthesis, protein biosynthesis, glycogen biosynthesis, purine 
and pyrimidine biosynthesis, amino acid metabolism, lipid and steroid biosynthesis, 
glycolysis, the TCA cycle, fatty acid oxidation, electron transport chain, antibiotic 
biosynthesis, the urea cycle and cyclic AMP degradation.38
1.3.3 Substrate Channeling in Metabolons
The most remarkable feature of metabolons is substrate channeling, which refers to 
directed or facilitated mass transport between active sites of two functionally connected 
subunits in a multifunctional protein or a multienzyme complex38,43. Based on previous 
studies, substrate channeling can be realized by two distinct mechanisms: direct transfer 
through a physical tunnel in the complex or an electrostatically favored highway at the 
complex surface. The former is more likely found in static metabolons or multifunctional 
proteins through allosteric interactions between active sites.43-45 To restrict water molecule
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accessibility, physical channels are hydrophobic and embedded inside proteins where 
intermediates are usually covalently bound to specific residues. During a single turnover, 
intermediates are transferred quickly and irreversibly to the next active site without 
accumulation.46,47 In the latter situation, surface charges are rearranged to form continuous 
patches linking the active sites. As a result, oppositely charged intermediates are still held 
close to the surface and guided to desired sites through electrostatic interactions.48-51 
Compared to physical channeling, electrostatic channeling is less efficient in avoiding 
escape o f intermediates into aqueous phase (leaky channeling), but it enables more flexible 
regulation on metabolic flux in metabolons.
When studying the TCA cycle metabolon in mitochondria permeabilized by toluene, 
Robinson et al. observed a 3-fold acceleration in coupled reaction rate between mMDH 
and CS, compared to that of equivalent free enzymes52. This kinetic improvement was 
attributed to a combination of several benefits brought by channeling compared to free 
diffusion of intermediates. (1) Spatial distance between active sites and time for mass 
transport are both reduced. (2) Loss of intermediates during diffusion is prevented. (3) 
Kinetic parameters are optimized to improve cascade coupling efficiency. (3) 
Thermodynamically unfavorable equilibria are circumvented by fast depletion of products.
(4) Labile intermediates are protected from reactive species and competing pathways. (5) 
Transfer of metabolites on metabolon surface is less affected by the crowded bulk 
environment.43,44
1.3.4 Methods of Demonstrating Substrate Channeling
Substrate channeling had been under debate on its actual existence and kinetic 
significance due to the lack o f direct evidence. According to the hypothesis, substrate
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channeling is a fast transient process (more than 1000 s-1)46 occurring within a very short 
distance (probably less than 10 nm).50 In other words, it is almost impossible to directly 
monitor channeling of small metabolites (mostly not detectable) in situ using traditional 
steady-state or microscopic methods. By X-ray crystallography, Davies et al. showed the 
first direct physical evidence for an indole tunnel between a -  and P-subunits in tryptophan 
synthase.43,44,53,54 There is more supporting structural evidence on intermediate tunnels in 
carbomoyl phosphate synthetase45, the family of glutamine amidotransferases55, 
thymidylate synthase-dihydrofolate reductase49, aKGDH complex56 and lumazine 
synthase/riboflavin synthase complex.57 However, for dynamic metabolons, X-ray 
crystallography is not feasible. In these cases, indirect approaches are utilized to 
characterize the channeling.
1.3.4.1 Isotope dilution. Isotope-labeled precursors are used to track radioactivity 
changes in multistep reactions. An excessive amounts of nonradioactive intermediates (I) 
in bulk solution will compete with endogenous radioactive intermediates (I*) and lower 
the ratio of radioactivity of labeled product (P*) to that of labeled substrate (S*). In the 
case of substrate channeling, I* will not be diluted by I and the radioactivity ratio (P*/S*) 
should be near unity.44,58
1.3.4.2 Transient-time analysis. Transient time is a key parameter for analyzing 
coupled enzymatic reactions. It refers to the intermediate lifetime during a catalytic cycle, 
which is the sum of time required for release of intermediate from the active site of the first
ES
I P
enzyme (Ei), diffusional transit to the second enzyme (E2) and binding to the active site of 




The first reaction proceeds constantly within the sampling period at rate of vi, and the rate 
constant k  of the transient process can be taken as the apparent first order rate constant of 
the second reaction. Then the following relationships can be obtained:
[P] = vi t -  J  (1-e-*)
[I] =  J  (l-e -kt)
1 — 1 _  kcat2\'E2\ _  w i j sk = "  = 77 = Vmax2/Km2
t  Km2
In coupled enzyme activity assays, transient time, t , is derived from the interval 
between the starting of sequential reactions upon mixing enzymes with substrate and the 
time when final product formation reaches its maximal rate (Figure 1.4).42,58,59
1.3.4.3 Competing reactions. In vivo intermediates are always subject to more than 
one metabolic pathway. In a free-diffusing system, escaped intermediates will be captured 
by an additional competing enzyme (Ec), generating another product (Pc) that can be 
monitored by a spectrophotometer. As a result, formation of its original product will be 
reduced, but in the direct transfer system, intermediates are not trapped by Ec and product 
formation is not affected. However, this method is only practical when Ec does not interact 
with examined enzymes.44,58
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Figure 1.4 Transient time in an enzymatic coupled reaction. Red dashed line is drawn from 
the linear steady-state phase in the product concentration curve versus time and 
extrapolated to the time axis.
1.3.4.4 Transient-state or fast kinetics. Transient-state kinetic measurements are 
designed to monitor a single turnover at sufficiently short time increments with enough 
enzyme amount (from several to hundreds of micromolar). Thus it can, in principle, probe 
intermediate and enzyme forms as well as their transitions at molecular level. A commonly 
used technique is the chemical quench-flow method. Generally, it mixes enzyme and 
substrate very rapidly with controllable syringes, followed by quick termination of reaction 
by another quenching agent at a certain point of time. With this method, any detectable 
spectral changes associated with transitions of enzymes, intermediates and products can be 
quantified.58,60
1.3.4.5 Computer simulation. Brownian dynamics (BD) simulation combined with 
experimental results has been used in studying intermediate motion under the influence of 
random collision with solvent molecules and interactions with the electrostatic field of the 
enzyme. Using this approach, Elcock et al. demonstrated an over 80% efficiency of 
transferring 7,8-dihydrofolate in thymidylate synthase-dihydrofolate reductase, which is 
highly consistent with the experimentally observed decrease in transient time.61
1.3.5 Significance of Metabolons to Enzymatic Biofuel Cells
The current generated at an enzyme cascade-modified bioanode is mainly affected 
by catalyst loading, local substrate concentration and the length for intermediate diffusion 
between sequential enzymes. Applying metabolons as the bioelectrocatalysts in a BFC, the 
current will in principle be enhanced as a consequence of (1) increased loading capacity on 
electrode surface with dense packing (confined spatial organization) of enzymes, (2) 
increased local substrate/intermediate concentration and (3) decreased transit time due to 
close proximity and substrate channeling within metabolons.33 However, there are few
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examples of using natural metabolons directly in enzymatic BFCs. This is because of the 
hindrance in isolation of intact dynamic complexes. In one pyruvate/air BFC, 
Moehlenbrock et al. provided a relatively simple method. They chemically cross-linked 
the TCA cycle metabolon in situ before rupturing the mitochondria membrane. The crude 
lysate containing fixed intact metabolons was directly co-immobilized with modified 
Nafion® polymer onto the anode. The resultant maximum current density increased by 
nearly 50% as compared to native lysate. Although the power density was low (around 24 
|iW/cm2), which was probably due to the presence of unwanted materials and cross-linker 
deactivation, this system is still a plausible proof of the potential advantage of metabolons 
as bioelectrocatalysts for enzymatic BFCs.62
1.4 Designing Artificial Metabolons 
In the realm of in vitro multienzyme biocatalysts, the bottleneck is the fragility and 
difficulty in isolation o f intact natural metabolons. Therefore, considerable efforts have 
been put into making artificial metabolons with enhanced stability and substrate channeling. 
However, making a metabolon biomimic does not mean just bringing enzymes together. 
The three-dimensional orientation o f enzymes is crucial for the formation o f substrate 
channeling across the interface. Different fixation and immobilization strategies have been 
exploited to achieve this goal.63
1.4.1 Cross-Linked Enzyme Crystals or Aggregates
Cross-linking can be simply done by conjugating two interacting enzymes in 
solution. This often requires a bifunctional reagent (cross-linker) that can react with two 
distinct residues (mostly lysine and cysteine) on proteins, thus creating cross-linked 
enzyme crystals (CLECs) or precipitated aggregates (CLEAs) when crystallization is not
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feasible. A common issue with cross-linking is the enzyme deactivation by small cross­
linkers. Larger or even polymeric cross-linkers can avoid this problem, but they may also 
lead to overaggregation or formation of unwanted complexes.64,65
1.4.2 Encapsulation of Enzyme Cascade
The whole metabolic pathway may be encapsulated into a nanocontainer, which 
can be micelles, liposomes, polymersomes or even virus capsids. Ideally, the container 
should have the right size for holding all sequential enzymes in close proximity and 
allowing them to adopt the appropriate conformation. In practice, this method has been 
extensively employed for single to three enzymes, but encapsulation of the entire pathway 
is technically difficult. Moreover, materials used for fabricating nanocontainers may 
interact with enzymes and interfere with desired protein-protein interactions. 
Encapsulation will also bring additional barriers for mass transport and electrode-enzyme 
communication.66-69
1.4.3 Oriented Co-localization to a Scaffold
Using genetic modification, a number of affinity tags can now be fused to proteins 
at specific sites. To a particularly selected or designed scaffold, multiple enzymes can be 
positioned at desired location with restricted orientation. Polyhistidine-tagged (usually at 
C- or N-terminus) enzymes can be chelated to Ni2+-plated surface.63 Enzymes bearing 
cellulose binding domain (CBD) can be co-immobilized onto one cellulose support. For 
example, a macromolecular complex named cellulosome from anaerobic cellulolytic 
bacteria has multiple CBD-affinitive domains, allowing co-localization of an enzyme 
cascade.70,71 Protein and nucleic acid scaffolds are attracting increasing interest because of 
their flexibility in shape and dimension. Proliferating cell nuclear antigen (PCNA), a ring­
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shaped protein scaffold, was used to establish a three-enzyme complex that gained 
significantly higher electron transfer efficiency than a free-enzyme system.72 An artificial 
protein scaffold was also investigated by combining specific protein-protein interaction 
domains for enzymes of interest and proved to achieve optimized metabolic flux.73 DNA 
and RNA scaffolds are examined to assemble enzyme cascades into different shapes, from 
one-dimensional strands to two-dimensional triangles. These strategies can facilitate 
ordered organization of enzymes on restricted locations; however, they actually cannot 
control the relative orientation of enzymes as natural metabolons do.74-76
1.4.4 Genetically Fused Multienzyme Complex
Enzyme cascades can be expressed as a multifunctional protein by fusing respective 
genes into one encoding all the active sites. Translated polypeptide chains will fold in vivo 
with the original tertiary structures of individual enzymes retained. The resultant fusion 
protein is then subject to regular isolation/purification procedures for further in vitro 
application. Shatalin et al. coupled two TCA cycle enzymes, mMDH to CS, by gene fusion 
and showed the evidence of channeling of oxaloacetate in the presence of a competing 
enzyme.51 Another example is a three-enzyme protein consisting of P-galactosidase, 
galactokinase and galactose dehydrogenase, which also demonstrated substrate channeling 
with decreased transient time and increased steady-state reaction rate.77 Even though gene 
fusion has the advantage in making robust artificial metabolons in the absence of any 
additional scaffolds, it may cause failure in folding of higher ordered (more than three 
enzymes) fusion proteins.63
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1.4.5 Site-Specifically Conjugated Enzyme Complex
Another elegant establishment of artificial metabolons is site-specifically 
conjugated multienzyme complexes. Rather than being folded as a whole protein in vivo, 
intact enzymes can be hybridized in vitro through linkages at specific modified residues, 
such as lysines, cysteines, tyrosines, tryptophans and even nonnatural amino acids. Site- 
directed mutation will turn amino acids of interest into either specifically tagged or reactive 
residues. Specifically tagged residues can be directed to a particular spot on the other 
enzyme and bridged by the attached linker. Reactive residues will directly target its 
interacting partner in very close proximity without additional linkers. Both protocols are 
highly selective and avoid potential activity loss caused by traditional chemical cross­
linking. The resultant conjugated complexes often regain their native orientations in vivo 
and exhibit substrate channeling.77-79 One example is the bioconjugation of 
monooxygenase cytochrome P450, putidaredoxin (Pdx) and Pdx reductase done by 
Hirakawa et al. This synthetic complex achieved a drastic enhancement in electron transfer 
rate between active centers.80 As a prerequisite for this strategy, structural information on 
protein-protein interactions should be provided in order to choose the candidate residues 
for site-specific mutation.
In summary, covalent or noncovalent, solution-based or scaffold-based, chemical 
or genetical strategies have been exploited for metabolon mimics. Each of the methods 
discussed above has its own advantages and drawbacks, but the ultimate goal of all is to 
mimic efficient substrate/intermediate channeling. So far, most of these trials have been 
made for synthetic purposes, except that encapsulation and scaffold-mediated co­
immobilization are under frequent investigation for improving bioelectrocatalytic
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efficiency. Genetic manipulation opens a new gate into rational design of synthetic 
metabolons.
1.5 Aims of Dissertation Research 
This dissertation work is aimed at understanding the fundamental nature of the TCA 
cycle metabolon from mechanistic and structural perspectives. By exploring the basic 
driving force for protein-protein interactions in mitochondrion, this research focuses on 
connecting studies of natural metabolons and artificial metabolons including engineered 
complexes for further catalytic application in enzymatic BFCs.
Uneven distribution of metabolites (metabolite pools) is a phenomena characteristic 
of metabolons in vivo. According to recent progress on enzymatic nanomotors, chemical 
concentration gradients may play a nonnegligible role in localization and 
compartmentation of metabolic pathways. Chapter 2 describes the mechanism study of the 
transport of mMDH and CS in response to substrate concentration gradient in a 
microfluidic channel.
As the first enzyme, CS links glycolysis and the TCA cycle, which makes it a good 
starting point for investigation of the whole metabolon. In Chapter 3, a structural study 
focused on interactions between CS and its two functionally connected partners, mMDH 
and ACO, is described. In vivo cross-linking and mass spectrometry was utilized to screen 
interacting residues, and computer-aided protein docking was involved to solve the 
structure of the natural mMDH-CS-ACO association.
Chapters 4 and 5 discuss two strategies of making metabolon mimics in vitro. In 
Chapter 4, different polymeric platforms were evaluated by FRET imaging to characterize 
their respective confinement effect on the organization of mMDH, CS and ACO. Work
26
described in Chapter 5 was done in collaboration with Dr. Scott A. Banta at Columbia 
University on an artificial metabolon using engineered mMDH and CS. This dissertation 
will discuss the structural analysis of cross-linked recombinant complexes by mass 
spectrometry and protein docking, and spectrophotometric characterization of substrate 
channeling.
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CHAPTER 2
INTERMEDIATE CONCENTRATION GRADIENT MEDIATED TCA CYCLE
METABOLON FORMATION
2.1 Background Introduction
2.1.1 Mass Transport in Solution
Three types of mass transport can occur in an aqueous phase: diffusion, migration 
and convection. Diffusion is the random motion of a molecule (i) with the tendency to 
move down the gradient of chemical potential, such as a concentration gradient, 3Q(x)/3x. 
Migration is the movement of an ion driven by an electric field, such as an electric potential 
gradient, 3^(x)/3x. Convection occurs when a density gradient, a temperature gradient or 
an external force, such as stirring, drives the flow at a rate of v(x).
The diffusive motion of i in the x direction is a result of one-dimensional random 
walks that can be described by
Ax2 = 2D,-t
Where the diffusion coefficient, Di, is defined as the ratio of the mean-square displacement 
over time.
Di = Ax2/2t
The expansion of one-dimensional diffusion to two- and three-dimensional diffusion yields 
the following relationships:
Reprinted from  “Wu, F., Pelster, L. N., M inteer, S. D. Chem. Commun. 2015, 55, 1244” w ith perm ission from  the Royal Society o f  Chemistry
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Ax2 = 4D,t, D, = Ax2/4 t  
Ax2 = 6D,t, D, = Ax2/6 t  
The diffusion coefficient is a characteristic value used to quantitate the diffusivity of a 
species in a specific medium at a certain temperature. Physical studies on Brownian motion 
gives the following equation:
D, = h kBT
The diffusion of a spherical object in solution, however, results in a diffusion coefficient 
that is a function of its radius (r) and the dynamic viscosity (n) of the medium, as described 
by the Stokes-Einstein equation:
kBTD, = - ^ ~6nnr
In the absence of migration and convection, the one-dimensional diffusive flux in solution 
is in direct proportion to the concentration gradient, as described by Fick’s first law:
dC,(x)J ( x )  = -D , —d^x
When migration and convection are also present, the flux of i in the x direction is then
determined by the Nernst-Planck equation.1
dC ,(x) z,F 3^(x)J ( x )  = —D, — D, C,  + C,v(x)J 1 dx RT 11  dx ' w
2.1.2 Compartmentalization of Metabolites and Metabolon Formation
Early evidence of metabolons was provided by the observation of the cellular 
organization o f metabolites. It was discovered that precursors for different metabolic 
pathways are stored in discrete pools. Using the isotope-labeling technique, researchers
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were able to follow the partitioning of intermediary metabolites and estimate their pool 
sizes.2,3 As discussed in Chapter 1, restricted metabolite diffusion is attributed to 
macromolecular crowding and electrostatic channeling. Although in-depth research is 
ongoing, another question has been raised: would the intermediary metabolite pools induce 
formation of dynamic metabolons? Work on chemoreceptors and chemoattractants in 
motile bacteria indicated that the degree of receptor protein clustering during cell cycles 
might be regulated by its binding to the ligand.4 Norris et al. further suggested that the 
processing of a substrate through the metabolic pathway may promote the co-localization 
and reversible assembly of membrane transport proteins and downstream enzymes. 
Additionally, such dynamic organization would dissociate upon the depletion of substrate, 
making cellular metabolism more efficient and adaptable.5 They also proposed a 
conformation-driven sequential affinity enhancement mechanism to explain substrate- 
activated enzyme complexes. As suggested by their research, the affinity of a substrate- 
bound enzyme (in its active form) to its functional partner could be increased by 
conformation alteration, that is, enhanced protein-protein interactions by feedforward 
substrate activation. The activation would propagate along the metabolic pathway, 
resulting in a higher degree of protein clustering or aggregation. It has been pointed out 
that the accumulation of products, on the contrary, would introduce inhibition feedback on 
enzyme association. Although this hypothesis has not yet been validated with additional 
experiments, it is in agreement with the generally accepted theory that metabolon formation 
is closely related to metabolic regulation in terms of the change of metabolite 
concentrations. Interestingly, Bartholomae et al. observed a very weak but specific 
interaction between mMDH and ICDH in Bacillus subtilis, which was stimulated by a
cocktail of their substrates and cofactors including isocitrate, NADP+ and Mg2+, even 
though the two enzymes are not directly functionally connected in the TCA cycle.6
In the hypothesis proposed by Norris et al., apparent diffusion coefficient alteration 
upon substrate binding was specifically noted for its potential role in driving the formation 
of a static large proteolipid and complexed metabolon in the membrane.5 Recent progress 
on chemotaxic behavior of nanoparticles demonstrated that, with an increased diffusion 
coefficient in the presence of substrates, some single enzymes can move against a substrate 
concentration gradient in a similar fashion to a nanomotor.7-9 Knowing the heterogeneity 
of metabolite distribution in cells, the early question may be addressed based on the idea 
of metabolite-linked dynamic complexes and gradient-directed enzyme diffusion. It could 
be possible that the substrate/intermediate concentration gradient exerts a nonnegligible 
effect on “dragging” metabolic enzymes together. For instance, 
microcompartmentalization of intermediates might reversibly hold the dynamic association 
of the TCA cycle metabolon. To gain further understanding, additional clarity surrounding 
how model enzymes from the TCA cycle would physically react in response to a metabolite 
gradient is required.
2.1.3 Structure and Catalytic Mechanism of mMDH
As introduced in Chapter 1, mMDH catalyzes the last reaction of the TCA cycle, 
in which L-malate is oxidized to OAA. This reaction involves NAD+ as the cofactor of 
mMDH and is highly reversible. In solution, mMDH is at the equilibrium between its 
monomeric, dimeric, and tetrameric forms. Interestingly, the homodimer was previously 
determined to be the most stable form as it does not undergo dissociation even at 1 nM.10 
Tetramer formation is enhanced at enzyme concentrations higher than 0.67 |iM. However,
35
under physiological conditions, ATP shifts the equilibrium towards the mMDH tetramer 
with a greatly decreased dissociation constant.11 It is widely accepted that the dimeric form 
is more critical for mMDH activity. For pig heart mMDH, each subunit (composed of 314 
amino acids) contains one binding site for NAD+/NADH and one active site for L- 
malate/oxaloacetate in its C-terminal domain (Figure 2.1A). Dimerization constructs two 
clefs with other catalytically necessary residues for accommodating substrates into the 
active site.12 Previous kinetic studies have shown that mMDH-catalyzed malate 
dehydrogenation is an ordered mechanism. Substrate binding follows the prebinding of the 
NAD+ cofactor to mMDH. Formation of the NAD+-mMDH-L-malate complex induces a 
conformational change in mMDH, where the hydrophobic active site vacuole is closed by 
an external loop to terminate solvent access. A histidine-aspartate pair in the vacuole 
establishes a charge relay system that allows proton transfer from L-malate to NAD+.13-17
Catalytic performance of mMDH is allosterically regulated. Considering the fact 
that the conversion of L-malate to OAA is thermodynamically unfavorable (+6.69 kcal)18, 
it is expected that excessive quantities of L-malate will facilitate OAA production, while 
accumulated OAA will inhibit mMDH. In addition, citrate (a product of its subsequent 
reaction) regulates mMDH activity in a complex manner. It competitively inhibits L-malate 
dehydrogenation at low [L-malate] or [NAD+], but activates mMDH at high [L-malate] or 
[OAA].19,20
2.1.4 Structure and Catalytic Mechanism of CS
CS is the first enzyme of the TCA cycle and the subsequent enzyme of mMDH by 
catalyzing a Claisen condensation of OAA and acetyl-CoA to citrate. In a similar fashion 
to mMDH, pig heart CS is stable in its dimeric form, where each subunit consists of 437
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Figure 2.1 Structures of pig heart mMDH (A, PDB ID: 1MLD) and CS (B, PDB ID: 1CTS).
amino acids and two separate binding sites for OAA/citrate and acetyl-CoA/CoA (Figure 
2.1B).21 The overall reaction is an ordered progress in three steps: (1) a proton abstraction 
from acetyl-CoA to form an enolized thioester group, (2) condensation of the enolate anion 
and carboxyl group of OAA to form a citryl-thioester, and (3) citryl-thioester hydrolysis to 
form citrate and CoA. OAA binding increases the binding constant of CS to acetyl-CoA 
by at least 20 folds, however, the binding constant of CS to OAA decreases if acetyl-CoA 
binds first.22-24 Crystallographic studies have demonstrated that CS undergoes significant 
shift/rotation of its helices and domain movement upon binding to different ligands. It 
exhibits a transition between the “open” and “closed” forms of conformation. In its open 
form, key residues for OAA/citrate accommodation are too far from each other and only 
28% of enzyme surface is accessible to solvent molecules. If acetyl-CoA binds first, CS 
switches to one of the closed forms. The active site for OAA/citrate, however, is deeply 
buried and completely inaccessible to solvent. It is suggested that prebinding of OAA 
induces a favorable alteration from the open form to another closed form that bears a well- 
defined binding site for acetyl-CoA. In this conformation, proton abstraction and 
condensation occur to form citryl-CoA, which consequently induces the completely closed 
form for hydrolysis by bound water. Once citrate and CoA are formed, CS must open to 
release the products.24-26
2.1.5 In Vitro System for Enzyme Transport Study
Sengupta et al. designed a microfluidic device enabling direct characterization of 
enzyme transport in the presence of a substrate gradient in vitro}’9 As illustrated in Figure 
2.2A, a Y-shaped polydimethylsiloxane (PDMS) microfluidic channel was utilized to 
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Figure 2.2 Experimental setup of the PDMS microfluidic channel.
different chemical components, infused by a dual syringe pump through separate inlets into 
the channel. To avoid turbulent flow, injection was conducted very slowly to maintain a 
low Reynold’s number in the fluid. According to Fick’s first law, there would be a cross­
channel flux of solute from the higher concentration regime to the lower concentration 
regime. This can be considered as a simulation of the metabolite concentration gradient 
inside cells or mitochondria. If the gradient can direct single enzyme diffusion from the 
opposite side, enhanced lateral flux of enzymes toward the concentrated metabolite regione 
should be observed. When two sequential enzymes are both applied, production of an 
additional intermediate gradient around the first enzyme might attract the second enzyme 
to its vicinity, leading to enhanced lateral co-diffusion (Figure 2.3).
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Figure 2.3 Schematic illustration of enhanced diffusion of mMDH and CS in the presence 
of a concentration gradient of substrate (L-malate) and intermediate (OAA).
2.1.6 Fluorescent Characterization of Enzyme Transport
Fluorescent imaging is a powerful technique in visualizing protein localization and 
partitioning. By tagging certain amino acids on a protein’s surface by small fluorescent 
probes, one can measure the emissive intensity o f fluorophore-labeled proteins in an area 
of interest under a microscope. In this chapter, two commercial probes (AlexaFluor® 488 
and AlexaFluor® 555) were used to modify two model enzymes, mMDH and CS. These 
probes belong to the family o f succinimidyl ester fluorophores, which can selectively react 
with the primary amine in the side chain of lysine residues and conjugate the fluorescent 
moiety onto the protein’s surface. Since AlexaFluor® 488 and AlexaFluor® 555 have 
distinct excitation and emission wavelength ranges, fluorescence of two tagged enzymes 
were monitored independently. Lateral enzyme transport was observed by cross-sectional 
emission intensity profiles. In the case of enhanced lateral enzyme transport induced by 
substrate/intermediate gradient, the intensity profile would shift by some extent to the other 
side of channel. To quantify enzyme transport, lateral shift (l) was defined as the linear 
distance from the middle point of the channel to where the normalized intensity is 0.5 at 
the same plane (Figure 2.4). Enhanced lateral enzyme transport resulted in an increase of
I. Taking I as how far the enzyme can move during a limited period of time (t), one can use 
the one-dimensional random walk rule to calculate its apparent diffusion coefficient, Dapp:
_  l2 
Dapp = 2t
2.1.7 Aims
To figure out the mechanism for metabolon formation in a heterogeneous 


















Figure 2.4 Flow containing fluorophore-labeled enzymes in the channel under microscope 
(A) and lateral shift of emission intensity (B).
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might be favored by the collective directional diffusion o f subsequent enzymes induced by 
an intermediary metabolite concentration gradient between them. To validate this 
hypothesis, diffusive motion o f two TCA cycle enzymes in response to different in vitro 
substrate/intermediate gradients will be investigated.
2.2 Experimental
2.2.1 Materials
Pig heart mMDH, CS, and all chemicals used in this work were purchased from 
Sigma-Aldrich unless otherwise noted. AlexaFluor® 488 and AlexaFluor® 555 for enzyme 
labeling were obtained from Invitrogen (Life Technologies). PDMS was purchased as part 
of the “Silicone Elastomer Kit” from Corning.
2.2.2 Labeling of Enzymes
AlexaFluor® 488 and AlexaFluor® 555 were used to label mMDH and CS, 
respectively. Approximately 1 mg o f mMDH or CS were purified over a prepacked 
Sephadex™ G-25M column (GE Healthcare) to remove ammonium sulfate and other salts. 
After being concentrated to approximately 2 mg/mL, the enzymes were mixed with a single 
vial of dye (as purchased) predissolved in 50 |iL of dry DMSO in 1 mL of 50 mM sodium 
phosphate buffer (pH 8.3). Mixtures of enzymes and fluorophores were incubated in the 
dark at room temperature for at least 1 h under shaking. Following labeling, excessive 
fluorophores were removed by overnight dialysis in a dialysis cassette with a molecular 
mass cutoff of 10 kDa (Thermo Scientific) against 2 L of Tris-HCl buffer (50 mM, pH 7.4) 
at 4 °C. Additionally, the enzymes were purified through a prepacked Sephadex™ G-25M 
column followed by multiple centrifugations in Amicon® centrifugal filters (10 kDa 
molecular weight cutoff, Merck Millipore) at 5000 x g for 15 min until polarization of
labeled enzymes was stabilized at about 0.3. Final fluorophore:enzyme molar ratios were 
determined by a UV-Vis spectrophotometer (Evolution 260 Bio, Thermo Scientific) to be 
approximately 1:1.
2.2.3 Enzymatic Assays for Kinetic Measurements and Inhibition Studies
Reaction rates of mMDH-catalyzed L-malate conversion were measured in 100 
mM potassium phosphate buffer (pH 7.4) containing 100 nM mMDH, 5 mM NAD+, and 
L-malate at 0, 0.5, 1.0, 2.5, 5.0, 10.0, 25, 50 and 100 mM. NADH absorbance at 340 nm 
(millimolar extinction coefficient is 6.22 mM-1 cm-1) was monitored for 100 s in the UV- 
Vis spectrophotometer. Reaction rates of mMDH-catalyzed OAA conversion were 
measured in potassium phosphate buffer containing 2.5 nM mMDH, 0.15 mM NADH and 
OAA at 0.005, 0.01, 0.025, 0.05, 0.075, 0.1, 0.2 and 0.3 mM. NADH absorbance at 340 
nm was monitored for 100 s. Reaction rates of CS-catalyzed OAA conversion were 
measured in potassium phosphate buffer containing 100 nM CS, 0.2 mM acetyl-CoA, 0.4 
mM DTNB and OAA at 0, 0.2, 0.4, 0.6, 0.8. 1.0, 2.5, 5.0, 10, 25, 50, 75 and 100 mM. The 
absorbance increase of DTNB at 412 nm (milimolar extinction coefficient of 13.6 mM- 
1cm-1) was monitored for 100 s. Km values were determined by fitting reaction rate versus 
substrate concentration to the Michaelis-Menten model, by nonlinear regression. Ki values 
for the inhibition of mMDH by ATP were determined by fitting multiple plots of reaction 
rates versus L-malate concentrations with 1 mM NAD+ and ATP at 0, 1, 5, 10 25 and 50 
mM.
2.2.4 Coupled Enzyme Activity Assays
Reaction rates of citrate production from L-malate were measured in 100 mM 
potassium phosphate buffer (pH 7.4) containing 100 nM mMDH, 100 nM CS, 5 mM NAD,
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0.2 mM acetyl-CoA, 0.4 mM DTNB and L-malate at 0, 0.5, 1.0, 2.5, 5.0, 10, 25, and 100 
mM. The absorbance increase of DTNB at 412 nm was monitored for 2 min. Km values 
were determined by fitting the reaction rates versus L-malate concentrations to the 
Michaelis-Menten model by nonlinear regression. The citrate inhibition effect was 
evaluated in the same assay cocktail by adding in 10 mM citrate. ATP inhibition of mMDH 
was performed in the same assay cocktail by adding in 25 mM ATP, and the absorbance 
increase of NADH at 340 nm was monitored for 2 min.
2.2.5 Microfluidic Channel Fabrication
The silicon master pattern for the microfluidic channel was fabricated with SU-8 
Negative Photoresist (Microchem) to a height of 100 |im and a width of 240 |im (Figure 
2.2B) according to the soft lithography protocol described by Xia et al.21 An additional 
pattern was introduced close to the channel pattern at 400 |im from the start of channel to 
mark the position at which fluorescence would be measured. PDMS (premixed with curing 
agent and degased) was poured onto the master and cured at 75°C for 2 hours. PDMS was 
then cut and sealed by a microscopic glass slide after being cleaned in a plasma cleaner 
(PDC-32G, Harrick Plasma). All chips were equilibrated overnight after sealing.
2.2.6 Fluorescent Imaging Setup
Microdialysis tubing (Intech Laboratories) were used to connect the inlets of the 
PDMS chip to a dual syringe pump (Harvard Apparatus) and the outlet to a beaker for 
solution waste (Figure 2.2A). All solutions were filtered through syringe filters (0.2 |im, 
Corning) to remove particles and degassed for at least 15 min immediately prior to the 
experiment. The PDMS channel was filled with 30% isopropanol and then buffer to avoid 
bubble generation. Flow in the chip at pumping rate of 500 nL/min was monitored with an
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inverted microscope (Olympus IX71). Using a FITC filter cube (excitation: 467-498 nm; 
emission: 513-556 nm) and a TRITC filter cube (excitation: 532-554 nm; emission: 570­
613 nm), fluorescence of AlexaFluor® 488-labeled mMDH and AlexaFluor® 555-labeled 
CS was recorded simultaneously. Buffered solutions containing substrates and cofactors 
were injected through Inlet 1. Buffered solutions containing 100 nM AlexaFluor® 488- 
labeled mMDH or CS were injected through Inlet 2. The observed plane was adjusted to 
the middle height of the channel between the glass and PDMS plate to avoid any possible 
wall effects.
2.2.7 Calculation of Apparent Diffusion Coefficients of Enzymes
Since the dual syringe pump infusing rate was set at 0.5 |iL/min, the total 
volumetric flow rate in the channel was 1 |iL/min. Knowing that the channel is 240 |im in 
width and 100 ^m in height, we calculated the cross-sectional area to be 2.4 x 104 ^m2. By 
dividing the total volumetric flow rate by the cross-sectional area, the flow velocity was 
determined to be 694.4 |im/s. By defining t0 = 0 s at the junction at which the two flows 
met, the total diffusion time (t) for enzyme molecules at 400 |im from the start of channel 
was calculated by t = 400 ^m ^  694 |im/s = 0.58 s. Finally, the value of apparent diffusion 
coefficient was given by
l2
Dapp “  1.16 sec
2.3 Results and Discussion
2.3.1 Single and Coupled Enzyme Kinetics
When cofactors are in excess and do not change significantly during the specified 
time course, Michaelis-Menten parameters can be estimated by treating the enzymatic
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reactions as the simple second-order model, as discussed in Chapter 1. For mMDH, 
although it undergoes an ordered binding mechanism, the change of reaction rate with [L- 
malate] fits the Michaelis-Menten kinetic model well (Figure 2.5A). Km for L-malate was 
determined to be 4.45 mM, and the maximum turnover rate was determined to be 2.12 x 
10-3 ^mole/min (or 3.53 x 10-7 M/s), so the turnover number of L-malate per mMDH 
(dimer) was 3.53 s-1. For CS, Km for OAA was calculated to be 2.81 mM, and the maximum 
turnover rate was calculated to be 2.32 x 10-2 ^mole/min (or 3.87 x 10-6 M/s), with a 
turnover number of 38.67 s-1. The measured Km constants for both enzymes are one order 
of magnitude higher than previously reported values28,29. A decrease in substrate affinity 
and catalytic efficiency may be caused by deactivation during long term storage at -20°C 
and fluorophore modification at active sites or catalytically necessary lysine residues. 
When the two reactions were coupled, the apparent Km to L-malate was reduced to 0.76 
mM while the turnover number was 36 s-1. Thus, the final coupled catalytic efficiency (28%) 
was greatly improved as compared to the catalytic efficiency of single mMDH (0.5%) for 
L-malate conversion.
2.3.2 Lateral Diffusion of Single Enzymes against a Substrate Gradient
Unlike previously examined enzymes, such as catalase and urease, mMDH and CS 
require additional cofactors to perform catalysis and the enzymatic reactions are not as 
simple as the decomposition of hydrogen peroxide or the hydrolysis of urea, making the 
system more complex (albeit tunable) for a mechanistic study. To examine enzyme 
transport stimulated by the substrate concentration, the Dapp values of mMDH and CS 
without additional cofactors were initially measured, where catalysis did not occur. As
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Figure 2.5 Change of reaction rate with substrate concentration: (A) mMDH-catalyzed L- 
malate conversion to OAA, (B) CS-catalyzed OAA conversion to citrate, (C) mMDH/CS- 
catalyzed L-malate conversion to citrate.
shown in Figure 2.6, in the absence of catalysis the Dapp increased as more substrate was 
introduced and reached a maximum when the enzyme active sites were saturated. For 
mMDH, increasing the L-malate concentration from 0 mM to 50 mM resulted in an 
increase of Dapp from 3.88 x 10-7 cm2/s (l = 6.65 ^m) against buffer to a maximum of 1.03 
x 10-6 cm2/s (l = 10.81 |im) against 50 mM L-malate. For CS, increasing the OAA 
concentration from 0 mM to 10 mM also increased the Dapp from 7.25 x 10-7 cm2/s (l = 
10.66 ^m) against buffer to a maximum of 2.07 x 10-6 cm2/s (l = 15.36 ^m) against 10 mM 
OAA. Interestingly, the enhancement of the lateral shift of mMDH or CS did not require 
catalysis to occur, which subsequently ruled out self-electrophoresis induced by charged 
products or self-propulsion driven by environmental changes, including the alteration of 
local pH, ionic strength, and temperature associated with enzymatic reactions as potential 
driving forces. In this case, electrophoresis of enzymes has been considered. The external 
electric field created by the pool of charged species on the other side of channel could 
induce the electrophoresis of enzymes across the interface, which might be possible for 
enhance lateral flux of mMDH as L-malate and enzyme molecules (pI of 10)30 were 
oppositely charged under experimental conditions. However, electrostatic attraction is not 
convincing for OAA and CS molecules (pI of 6.1-6.6)31, both of which were negatively 
charged.
2.3.3 Lateral Diffusion of Single Enzymes Enhanced by Catalysis
After the addition of cofactors (5 mM NAD+ for mMDH and 0.2 mM acetyl CoA 
for CS), the change of Dapp with a substrate concentration gradient was quite different. In 
the presence of NAD+, the Dapp of mMDH showed a significantly larger increase (224%) 
from 4.82 x 10-7 cm2/s (l=7.41 |im) against 0 mM L-malate to 1.56 x 10-6 cm2/s (l = 13.45
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Figure 2.6 Apparent diffusion coefficient of single mMDH (A) or CS (B) in the presence
of increasing substrate concentration with and without cofactors.
|im) against 10 mM L-malate, as compared to a 116% increase in the absence of NAD+. 
This significant enhancement was consistent with previously reported related experimental 
results which concluded that catalysis enhances diffusion coefficient of single enzymes.7 
For CS in the presence of acetyl-CoA, the Dapp increased by 78% from 1.13 x 10-6 cm2/s (l 
= 11.45 ^m) against 0 mM OAA to 2.01 x 10-6 cm2/s (l = 15.27 |im) against 5 mM OAA. 
As compared to the 127% increase in the absence of acetyl-CoA, however, the 
enhancement of Dapp was reduced. This unexpected change may be caused by “prebinding 
competition to CS” between OAA and acetyl-CoA. As discussed earlier in this chapter, if 
OAA binds first, a favorable closed form of CS is induced for acetyl-CoA recognition and 
catalysis ensues. If acetyl-CoA binds first, however, the active sites in CS are completely 
blocked from further binding to OAA.
Another interesting finding was the lowering of substrate concentration for 
maximum Dapp (10 mM L-malate for mMDH and 5 mM OAA for CS) in the presence of 
cofactors. The reduction of directional enzyme diffusion at high substrate concentration 
could be explained by competitive binding between substrate and product to the same 
active site during the catalytic cycle. If the Vmax is reached quickly, generating a local pool 
of products, an inhibitory feedback effect might prevent the active sites from binding more 
substrates. To test whether product concentration would also affect enzyme movement, we 
studied mMDH diffusion directly against an OAA concentration gradient. As shown in 
Figure 2.7, the Dapp of mMDH was again in direct proportion to the concentration of OAA. 
Its value is comparable to that measured with L-malate, albeit achieved at a much lower 
OAA concentration. This is likely because the binding affinity of OAA to mMDH and the 
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Figure 2.7 Kinetics of mMDH-catalyzed OAA conversion to L-malate (Top) and apparent 
diffusion coefficient in the presence of increasing [OAA] with and without NADH 
(Bottom).
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0.025 mM and turnover number was 562 s-1).
2.3.4 Co-diffusion of mMDH and CS Enhanced by Intermediate Production
Results on the dynamics of the single enzymes demonstrated the collective 
directional transport of mMDH or CS stimulated by a metabolite concentration gradient, 
which encouraged us to continue exploring the potential role of the intermediate in driving 
co-diffusion of mMDH and CS. As shown in Figure 2.8, when the two enzymes were 
infused together against L-malate and cofactors, coupled production of citrate from L- 
malate began at the flow interface. The Dapp of mMDH increased from 4.9 x 10-7 cm2/s (l 
= 7.54 ^m) against 0 mM L-malate to a maximum of 1.5 x 10-6 cm2/s (l = 13.19 |im) against 
5 mM L-malate. Meanwhile, an enhancement in CS lateral diffusion occurred with the Dapp 
increasing from 8.8 x 10-7 cm2/s (l = 10.10 |im) to a maximum of 1.9 x 10-6 cm2/s (l = 
14.85 |im). A reduction of Dapp when [L-malate] was greater than 10 mM could be 
attributed to allosteric inhibition of mMDH by locally accumulated citrate.
As a control, the same measurement in the absence of cofactors was performed to 
test if coupled catalysis is necessary for enhanced co-diffusion. As shown in Figure 2.9, 
however, even without the generation of the intermediate (OAA) the Dapp of both enzymes 
increased until mMDH was saturated by 10 mM L-malate. By removing mMDH, the Dapp 
of CS gradually decreased as [L-malate] increased, suggesting that the observed co­
diffusion might be due to another contribution. The most plausible explanation is the 
intrinsic “linkage” between mMDH and CS. This was supported by blue Native gel 
electrophoresis, which is a general tool used to detect protein-protein interactions by 
estimating their molecular weight. In Figure 2.10, an additional band appeared around 248 
kDa, which related to the interaction between one mMDH tetramer and one CS dimer (35.9
54
25
0 mM 1 mM 5 mM 10 mM 50 mM
[L-malate]
Figure 2.8 Apparent diffusion coefficients of mMDH and CS measured against increasing 
[L-malate] and 5 mM NAD+ and 0.2 mM acetyl CoA.
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Figre 2.9 Apparent diffusion coefficients of mMDH and CS measured against increasing 
[L-malate] without cofactors. Inset is the apparent diffusion coefficient of single CS 












Figure 2.10 Blue Native gel electrophoresis of individual mMDH, CS and mixture of 
mMDH and CS. Enzyme concentration was kept at 100 nm.
kDa x 4 + 52 kDa x 2 = 247.6 kDa). This seemed contradictory towards the common idea 
that protein-protein interactions or metabolon formation is favored under very concentrated 
states (hundreds o f micromolar concentrations), while the protein concentration in our 
experiment was kept at only 100 nM. Additionally, these results also surprisingly revealed 
mMDH to be in its tetrameric form (band at around 146 kDa). As a result, the Dapp of 
mMDH measured throughout the experiments was always smaller than the Dapp of CS. This 
can only be explained by tetramerization of mMDH in solution, otherwise the Dapp of the 
mMDH dimer should be larger based on their relative sizes (Stokes-Einstein equation).
Herein we hypothesized that it was not a strong physical interaction but rather a 
dynamic (probably electrostatic) association that facilitated the co-diffusion of CS with 
mMDH. To verify this theory, we infused mMDH and CS separately in two flows. As 
shown in Figure 2.11, CS exhibited a weak affinity to mMDH, which gave a slight increase 
(16%) in Dapp from 7.2 x 10-7 cm2/s (l = 9.14 |im) to 8.4 x 10-7 cm2/s (l = 9.88 |im). 
Following the addition o f L-malate and cofactors to initiate OAA production, CS diffused 
toward mMDH faster with its Dapp increasing by 33% (10 mM), 55% (50 mM) and 75% 
(100 mM). Therefore, this indicates that intrinsic mMDH-CS attraction had a minor effect 
on co-diffusion. Generation o f intermediate between separated mMDH and CS would 
significantly decrease their proximity, even though the resultant association is dynamic and 
reversible.
2.3.5 Mechanism for Intermediate Gradient-Induced Co-diffusion
Studies on self-propulsion at the nanoscale indicated several mechanisms that could 
potentially drive the chemotaxis-like behavior of enzymes. A gradient created across the 















Figure 2.11 Apparent diffusion coefficient of CS measured against mMDH and L-malate 
with cofactors on the other side of channel.
enzyme in the opposite direction to the molecular flux down the gradient. Depending on 
whether it is a concentration gradient or an electric field, this phoretic flow is termed 
diffusiophoresis or electrophoresis. If the gradient is generated locally by the enzyme itself,
i.e. a pool of charged product near its surface, the enzyme sphere may “swim” against the 
local gradient like a Brownian ratchet. According to Brownian simulation, self- 
diffusiophoresis or self-electrophoresis can increase the diffusion rate by up to fifty times.32 
This theory appears to explain observed augmentation in the Dapp of mMDH and CS. 
However, it does not explain the plateau in diffusion rate following saturation of the 
substrate. One possible reason is the decreased diffusion coefficient in high viscosity 
associated with high sugar content. This has been proven by control experiments. By using 
unrelated enzymes (a-ketoglutarate dehydrogenase (aKGDH) and alcohol dehydrogenase 
(ADH)) or substrate (fumarate, another TCA cycle metabolite that is structurally similar to 
L-malate), we demonstrated that the Dapp decreased with increasing metabolite 
concentration (Figure 2.12).
Although the physics for directed enzyme transport induced by a substrate 
concentration gradient remains to be fully established, conformational transition upon 
ligand binding is accepted as playing an important role in altering the enzyme motion. 
Therefore, as we observed, the change of Dapp tended to follow specific substrate-active 
site binding equilibria and enzyme kinetics. Binding of NAD+ and L-malate to mMDH 
occurs in an ordered manner with a conformational change around active sites upon the 
formation of the mMDH-NAD+-L-malate complex. For CS, binding of OAA can directly 
induce domain movement and internal rearrangement of amino acid side chains. 
“Conformation oscillation” between free and bound states would at least enhance the
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Figure 2.12 Apparent diffusion coefficient of (A) aKGDH and ADH measured against L- 
malate with 5 mM NAD+, and (B) mMDH and CS measured against fumarate with 5 mM 
NAD+ and 0.2 mM acetyl CoA.
rotational diffusion of enzyme molecules, particularly when enzymes are relatively large 
(over 100 kDa). Hence, with more ligands present, more binding events would occur to 
enhance the enzyme flux into an even higher concentration region, similarly as the 
Brownian ratchet driven by self-phoresis, until all available binding sites are occupied.
Work on DNA polymerase complexes performed by Sengupta et al. showed that 
cycles of non-reciprocal conformational alterations can increase its diffusion coefficient by 
almost 40%. In this work, individual lateral diffusion and co-diffusion were both 
significantly accelerated by catalysis.9 Through the complete catalytic cycle, conformation 
transition is accelerated by substrate turnover and product release, resulting in a greater 
acceleration factor on enzyme diffusion against a concentration gradient. It worth 
mentioning that the energy conversion during a catalytic turnover is not negligible in 
changing the enzyme diffusivity. As suggested by the latest work done by Riedel et al., 
heat released by enzymatic reactions may place a chemoacoustic effect that results in a 
center-of-mass acceleration of the enzymes.33
By interrupting the catalytic cycle with a competitive inhibitor (ATP), we were 
able to observe a consequent reduction in lateral diffusion. As shown in Figure 2.13, the 
Dapp of mMDH decreased consistently with the reaction rate as [ATP] increased. Such 
attenuation became less significant after 50% of mMDH molecules were inhibited. Similar 
results were obtained in the case of coupled reactions (Figure 2.14). Adding ATP into the 
channel led to a reduction o f directional transport for both enzymes. It should be noted that 
the Dapp of mMDH measured with cofactors and ATP (7.83 x 10-7 cm2/s) against 0 mM L- 
malate was 0.5% larger than that measured with just cofactors (4.90 x 10-7 cm2/s), and four 







Figure 2.13 Apparent diffusion coefficient of single mMDH measured with 5 mM L-malate 
and 1 mM NAD+ in the presence of increasing [ATP] equalized on both sides of channel. 
Inset is the reaction rate of mMDH-catalyzed L-malate conversion under same condition.
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Figure 2.14 Apparent diffusion coefficients of mMDH and CS measured with L-malate, 1 
mM NAD+ and 0.2 mM acetyl CoA in the presence of 25 mM ATP equalized on both sides 
of channel.
substrate but also other ligands can alter enzyme diffusivity. Continued additions of L- 
malate in the presence of 25 mM ATP, however, did not further enhance Dapp, since 
competitive binding of ATP to the nicotinamide binding site cannot induce favorable 
conformational changes for L-malate accommodation. Within mitochondria, where many 
metabolites are present, the concentration-mediated regulatory effect on enzyme motion 
and dynamic association will be more complex.
2.4 Conclusions
In this study, the directional transport of mMDH and CS against the concentration 
gradient in a microfluidic channel has been observed. Such chemotaxis-like motion can be 
promoted by catalysis and suppressed by inhibitors. Upon extension to a coupled enzyme 
system, the directional co-diffusion of both enzymes can be accelerated by sequential 
catalysis, demonstrating that local intermediate concentration gradients will enhance the 
dynamic association between mMDH and CS at very low protein concentrations. In the 
realm of bioelectrocatalysis, metabolons have become a hot spot for researchers seeking 
improved mass transport. Work described in this chapter is aimed at gaining physical 
insight into enzyme behavior affected by metabolite concentration and will help understand 
the dynamics of metabolon formation. This will also provide a new perspective toward 
artificial metabolons, since sequential enzymes may be functionally associated by their 
intermediates.
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CHAPTER 3
STRUCTURAL PROBING OF PROTEIN-PROTEIN INTERACTIONS AND 
SUBSTRATE CHANNELING IN THE TCA CYCLE METABOLON 
BY CROSS-LINKING AND MASS SPECTROMETRY
3.1 Background Introduction
3.1.1 Principles of Protein-Protein Interactions
Protein-protein interactions (PPIs) have important implications in elucidating 
intracellular organization of metabolic functions on the molecular point of view. In dilute 
solutions, PPIs undergo a diffusion-controlled process. It may require a long time for 
protein molecules diffusing translationally before they collide. Once encountered, they 
explore each other’s surface and rotate locally to adopt an optimal conformation 
orientation. In the translational step, diffusion rate can be greatly affected by external 
factors including medium viscosity, pH, temperature and ionic strength.1 Adding crowding 
agents, such as PEG, which simulates the crowded intracellular environment, can enhance 
protein-protein association rate by volume-excluding effect.2 In the rotational step, 
geometric constraints and specific residue interactions dominate the conformation 
adoption.1
Proteins interact through recognition between surface hot spots, which are highly 
conserved residues during evolution. Site-directed mutation of these sites will cause an
Reprinted from “Wu, F., Minteer, S. D. Angew. Chem. Int. Ed. 2015, 54, 1851” with permission from John Wiley & Sons, Inc.
increase of binding free energy by at least 2.0 kcal/mol and thus dissociation of protein 
complexes. Interfaces between binding partners have been shown to possess good surface 
shape and electrostatic complementarity, and typically have an area of 1200 ~ 2000 A.2.3-5 
Hydrophobic interactions turn out to be the major driving force as a large extent of nonpolar 
regions are buried in interfaces. This in fact thermodynamically stabilizes associated 
proteins due to water molecule expulsion and entropy increase.6,7 Meanwhile, the 
population of charged and polar residues are also found significant at interfaces, indicating 
a central role of electrostatic interactions in PPIs. Electric fields generated at the protein 
surface enhances the rotational diffusion at binding sites until the interfacial electrostatic 
complementarity is attained. Another noteworthy consequence is the surface charge 
rearrangement at non-buried areas that ultimately facilitates electrostatic channeling of 
substrate between enzyme active sites.8 In addition to hydrophobic and electrostatic 
interactions, amino acid side chains at interfaces form hydrogen bonds that also stabilize 
protein-protein association.3
3.1.2 Chemical Cross-Linking of Protein-Protein Interactions
Chemical cross-linking can be classified into in vivo and in vitro cross-linking. 
When applied in vivo, cross-linking reagents (cross-linkers) quickly capture obligatory or 
transient interactions, and stabilize protein complexes in native state. This method requires 
lipophilic cross-linkers that can penetrate the membrane. In vitro chemical cross-linking is 
usually done in solution by simply mixing cross-linkers with isolated/purified interacting 
proteins. Most cross-linkers are small bifunctional molecules with a spacer arm of several 
Angstroms. The distinct advantage is the capability of probing interfacial amino acids
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within a restricted distance in combination with other follow-up detection techniques, i.e. 
mass spectrometry.
The principle of chemical cross-linking is covalent conjugation of the functional 
groups of a cross-linker to specific surface amino acids on interacting domains. Lysines 
are the most frequently targeted residues because of their relatively high prevalence (6%) 
and reactivity (primary amine). Lysine-specific cross-linking is beneficial for producing 
stable native complexes at relatively high yields as long as the reaction conditions are 
carefully controlled, although it sometimes cannot distinguish desired PPIs from random 
artifacts. Other residues like cysteines and arginines can be targeted, however, they often 
suffer from low abundance, inefficient cross-linking, or unfavorable reaction conditions 
for native proteins.9
In this work, disuccinimidyl glutarate (DSG, structure shown below) is utilized to 
cross-link lysines on two interacting domains. DSG belongs to the family of amine-reactive 
N-hydroxysuccinimidyl esters. It can form two amide bonds with the primary amines of 
lysines and link them through a three-carbon spacer, which is 7.7 A in length. Since it is 
membrane-permeable, DSG is used for in vivo cross-linking of the TCA cycle metabolon.
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3.1.3 Separation of Cross-linked Protein Complexes
Containing nearly 10% of the cell protein amount, mitochondria can be isolated 
from bulk cytoplasm by differential centrifugation with their intact matrix organization 
protected by two double-layer membranes (outer mitochondrial membrane and inner 
mitochondrial membrane).10 In vivo cross-linking will generate a complex pool of fixed 
protein complexes of different sizes (molecular weight) packed tightly by the membranes. 
Before any further proteomic analysis, membrane disruption is needed. To break the 
membrane boundary, two common tools have been adopted: detergents and 
ultrasonication. Detergents are amphiphilic molecules bearing a polar head and a nonpolar 
tail, meaning that they can intervene between lipid molecules and membrane proteins. 
Beyond the critical micelle concentration (CMC), detergents start forming micelles that 
rupture the bilayer structure. Ultrasonication uses high-energy sound waves to break the 
bilayer or large lipid fractions into small pieces.
Once the membrane and matrix proteins are released, sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) isolates the protein complex of interest 
(the TCA cycle metabolon in this work) by sizes. SDS is also a surfactant whose 
hydrophobic tail can interact strongly with the protein backbone and destroy the tertiary 
structure (denaturing). Since that the binding occurs at a constant ratio of one SDS 
molecule to two amino acids, proteins acquire predictable number of negative charges on 
a peptide length or weight basis. In an external electric field, these negatively charged 
proteins will migrate through the chemically inert polyacrylamide mesh. For proteins with 
shorter chains and higher mass-to-charge ratios (m/z), they migrate faster than those with 
longer chains and lower m/z. When the migration is conducted in a gradient
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polyacrylamide gel which contains pores of decreasing sizes, small proteins with high 
mobility can migrate over a longer distance, whereas large protein complexes with reduced 
mobility will get stuck somewhere near the starting line. After electrophoresis, trapped 
proteins are visualized by various dyes (i.e. Coomassie, silver, fluorophores, etc.) and 
compared to standard markers of known molecular masses.11
3.1.4 Protein Digestion
In studying PPIs, researchers often intend to know the particular interacting 
residues or peptides. For this purpose, intact protein complexes are digested by trypsin into 
small fragments to distinguish conjugated peptides from native peptides. Trypsin is an 
endopeptidase that only cuts peptide bonds at C-terminal of arginine (R) or lysine (K). 
Typsin digestion is very specific and efficient in generating peptide fragments from 
denatured or native proteins for mass spectrometric analysis. There are several scenarios 
in which trypsin may fail: (1) two cleavable peptide bonds in consecutive positions (RR, 
RK, KR, or KK) which only lets trypsin cut one of them, (2) posttranslationally or manually 
modified R or K, and (3) R or K with a proline (P) on its C-terminal side. As a result, 
proteins are degraded into peptides bearing at least one R or K at C-terminus. In principle, 
they are 10 amino acids long on average, but in practice, the length spans a wide range. 
Nonetheless, peptides of 4~40 amino acids are usually taken for analysis.11,12
3.1.5 Mass Spectrometric Analysis of Peptides
Mass spectrometry is aimed at identifying charged species by their m/z and 
abundance. A bottom-up approach for mass spectrometric studies of PPIs includes 
separation of a mixture of tryptic peptides by high-performance liquid chromatography 
(commonly reversed-phase chromatography), ionization of tryptic peptides by energy
sudden ion generation or rapid desorption, analyzing o f charged peptides passing through 
an electric or magnetic field, and detection o f ion beams which are converted into readable 
spectra with m/z (unit: Th) peaks.13 Identification of a peptide-generated peak on a high- 
resolution mass spectrum is accomplished with its characteristic isotopic pattern, which is 
the separation o f isotopic peaks by charge. In spectra o f small ions or short peptide 
fragments, the strongest peak is always monoisotopic (first peak of an isotopic pattern), 
which refers to a composition of only most abundant natural isotopes (12C, 1H, 16O, 14N, 
32S, etc.), but as carbon number increases in longer peptides or proteins, chances of having 
one or more 13C also increases, indicated by rising of the subsequent isotopic peaks. For 
tryptic peptides of 1500 ~ 2000 Da, the isotope containing one 13C becomes the strongest. 
For peptides of 2000 ~ 3000 Da, the isotope containing two 13C is the highest, and so forth. 
The isotopic pattern will eventually become bell-shaped as peptide mass increases.14
To determine the accurate molecular mass (M) of a peptide carrying n charges from 
mass spectrometric data, one may first identify the monoisotopic peak at m 1, even though 
it is challenging when mass is huge. In the positive mode (peptide in form of [M + nH]n+), 
n is easily judged by the separation of the monoisotopic peak and second isotopic peak at 
m2 (or o f any two neighboring peaks in the isotopic pattern):
n =  1/(m2-mj)
Then M is derived by
M = n(m1-1.0078)
The mass error is defined as the difference between experimentally measured mass (Mexpt) 
and calculated exact mass (Mcalc) in parts per million (ppm)11
Mexpt-Mcalc .-------------- x 106 ppmMcalc
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3.1.6 Aims
Although extensive efforts have been made in assembling enzyme cascades 
(including the TCA cycle) into metabolon biomimics15, there is limited knowledge of how 
these enzymes interact with each other in natural metabolons. Combining protein 
engineering and computer modeling, Srere et al. proposed a symmetric model for the 
mMDH-CS-ACO complex as a part of the TCA cycle metabolon. To construct this model, 
they set the homodimer, CS as the core of the complex, whose C-terminus were fused to 
N-terminus of mMDH (also a homodimer), and N-terminus were respectively fused to C- 
terminus of two ACO monomers. With this intelligent structure, they managed to illustrate 
a continuous surface region of positive potential that may direct efficient substrate 
channeling by numerical simulation.16,17 However, organization of wild-type TCA cycle 
enzymes inside mitochondria is still in need of experimental proof. As claimed in Chapter
1, acquiring native structural information will undoubtedly promote rational design of 
artificial metabolons. Taking great advantage of mass spectrometry in proteomic studies, 
researchers now can probe the native structure of in vivo protein-protein networks, for 
which high-resolution techniques like X-ray crystallography are not feasible.12,18,19 In this 
work, in-vivo chemical cross-linking and mass spectrometry (XL-MS) were combined to 
identify interfacial residues in mMDH-CS-ACO complex. With distance constraints from 
XL-MS experiments, a low-resolution structure for mMDH-CS-ACO complex has been 




All chemicals were purchased from Sigma-Aldrich unless otherwise specified. 
Fresh beef heart was purchased from a local slaughter house.
3.2.2 Preparation of Intact Beef Heart Mitochondria
Mitochondria were isolated from fresh beef heart cells according to Pallotti’s 
procedure20 with slight modifications. Beef heart cut into small cubes was blended by a 
Waring laboratory blender in chilled isolation buffer (0.01 M Tris-HCl buffer, 0.25 M 
sucrose, 0.2 mM EDTA and 1 |iM PMSF, pH 7.8). Meat suspension was centrifuged at 
1200 x g for 20 min, and the supernatant (filtered through two layers of cheesecloth) was 
centrifuged at 26000 x g for 15 min. The pellet was homogenized in isolation buffer using 
a glass-Teflon homogenizer and centrifuged again at 26000 x g for 15 min. Supernatant 
was discarded and pellet resuspended in isolation buffer was centrifuged at 12000 x g for 
30 min. Mitochondrial pellet was homogenized in 20 mL of 0.01 M phosphate buffer 
containing 0.25 M sucrose (pH 7.8) and stored in small aliquots at -80 °C before use.
3.2.3 In Vivo Cross-linking of the TCA Cycle Metabolon
A mitochondrial aliquot was diluted in 10 mM PBS (pH 7.4) to a final protein 
concentration of 2 mg/mL. Fresh solution of DSG (Life Technologies), 3.26 mg dissolved 
in 50 |iL of dry DMF, was added to the mitochondrial suspension to a final concentration 
of 1 mM. The approximate DSG/protein molar ratio was 50:1. As a native control, 50 |iL 
of DMF containing no DSG was also added to a separate mitochondria suspension. Cross­
linking was incubated at room temperature for 30 min under gentle shaking and quenched 
by adding 100 |iL of 2 M Tris buffer (pH 8.3).
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3.2.4 Isolation of Cross-linked Matrix Protein Complexes
Cross-linked mitochondria were collected from suspensions centrifuged at 26000 
x g for 30 min and resuspended in 10 mL of lysis buffer (50 mM Tris, 150 mM NaCl, 2 
mM EDTA, 1 mM PMSF, and 0.5% sodium cholate, pH 7.4). Membrane disruption was 
done by homogenizing mitochondria suspension in a glass-glass homogenizer on ice and 
incubated at 4 °C for 30 min under gentle shaking. Lysed mitochondria were further 
sonicated by an ultrasonication probe (FB505, Fisher Scientific) in ice bath for 2 min (5 
sec on pulses and 15 sec off pulses). Membrane fractions were centrifuged down at 5000 
x g for 30 min. Unwanted large fractions and preaggregated proteins were removed by 
precipitating with 35% ammonium sulfate at 4 °C for at least 1 h under gentle stirring and 
centrifugation at 5000 x g for 15 min. Yellowish supernatant was then dialyzed in cellulose 
ester dialysis membrane (Spectro Por® Biotech) with a molecular mass cutoff at 100 kDa 
against 2 L of 50 mM Tris-HCl buffer (pH 7.4) at 4 °C overnight, and applied to a 
prepacked Sephadex™ G-25M column (GE Healthcare) to remove excessive salts and 
detergents. To separate proteins in dialyzed supernatant, reducing SDS-PAGE was 
performed on a 4-20% gradient gel (Thermo Scientific) according to the protocol provided 
by manufacturer.
3.2.5 In Gel Digestion of Protein Complexes
Gel bands of interest were excised and destained twice in 1 mL of 50% methanol 
with 50 mM ammonium bicarbonate at room temperature under gentle vortexing for 1 h. 
The gel slices were rehydrated in 1 mL of 50 mM ammonium bicarbonate at room 
temperature for 30 min, and the gel bands/spots of interest were cut into several pieces. 
These gel pieces were rehydrated in 1 mL of 100% acetonitrile at room temperature under
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gentle shaking for 30 min. Acetonitrile was carefully removed from the gel pieces with a 
pipette tip prior to trypsin digestion. Ten to twenty microliters of sequence-grade modified 
trypsin (20 ng/^L, Promega) in 50 mM ammonium bicarbonate was added and incubated 
with the gel pieces overnight at 37 °C. Digestion was quenched by adding 20 |iL of 1% 
formic acid. Then the solution was allowed to stand, and peptides that dissolved in the 1% 
formic solution were extracted and collected. Further extraction of peptides from the gel 
material was performed twice by adding 50% acetonitrile with 1% formic acid and 
sonicating at 37 °C for 20 min. All these solutions were collected and combined. A final 
complete dehydration of the gel pieces was accomplished by adding 20 |iL of 100% 
acetonitrile and incubation at 37 °C for 20 min. The combined supernatant solutions of 
extracted peptides were dried in a vacuum centrifuge (Speed-Vac). The peptides were 
reconstituted in 100 |iL of 5% acetonitrile with 0.1% formic acid for mass spectrometric 
analysis.
3.2.6 Mass Spectrometric Instrumentation
Peptides were analyzed using a nano-liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) system comprised of a nano-LC pump (Eksigent) and a LTQ- 
FT mass spectrometer (ThermoElectron Corporation). The LTQ-FT is a hybrid mass 
spectrometer with a linear ion trap used typically for MS/MS fragmentation (i.e. peptide 
sequence) and a Fourier transform ion-cyclotron resonance (FT-ICR) mass spectrometer 
used for primary accurate mass measurement of peptide ions. The LTQ-FT is equipped 
with a nanospray ion source (ThermoElectron Corporation). Approximately 5 to 20 
femtomoles of tryptic-digested or phosphopeptide-enriched samples were dissolved in 5% 
acetonitrile with 0.1% formic acid and injected onto a homemade C18 nanobore LC
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column for nano-LC-MS/MS. A linear gradient LC profile was used to separate and elute 
peptides, consisting of 5 to 70% solvent B in 78 min with a flow rate of 350 nL/min (solvent 
B: 80% acetonitrile with 0.1% formic acid; solvent A: 5% acetonitrile with 0.1% formic 
acid). The LTQ-FT mass spectrometer was operated in the data-dependent acquisition 
mode controlled by Xcalibur 1.4 software, in which the “top 10” most intense peaks 
observed in an FT primary scan (i.e. MS survey spectrum) were determined by the 
computer on-the-fly and each peak was subsequently trapped for MS/MS analysis and 
peptide fragmentation (sequencing by collision-induced dissociation). Spectra in the FT- 
ICR were acquired from m/z 400 to 1700 at 50000 resolving power with about 3 ppm mass 
accuracy. The LTQ linear ion trap was operated with the following parameters: (1) 
precursor activation time was 30 ms and activation Q was 0.25; (2) collision energy was 
set at 35%; (3) dynamic exclusion width was set at low mass of 0.1 Da with one repeat 
count and duration o f 10 s.
3.2.7 Mascot Database Searches
LTQ-FT MS raw data files were processed to peak lists with BioworksBrowser 3.2 
software (ThermoElectron Corporation). Processing parameters used to generate peak lists 
were as followed: (1) precursor mass was between 401 ~ 5500 Da; (2) grouping was 
enabled to allow five intermediate MS/MS scans; (3) precursor mass tolerance was set at 
5 ppm; (4) minimum ion count in MS/MS was set to 15, and minimum group count was 
set to 1. Resulting DTA files from each data acquisition were merged and searched against 
the NCBI or custom databases for identified proteins, using MASCOT search engine 
(Matrix Science Ltd; version 2.2.1; in-house licensed). Searches were done with tryptic 
specificity, allowing two missed cleavages or “nonspecific cleavage” and a mass error
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tolerance of 5 ppm in MS spectra (i.e. FT-ICR data) and 0.5 Da for MS/MS ions (i.e. LTQ 
Linear ion trap). Identified peptides were generally accepted only when the MASCOT ion 
score value exceeded 20.
3.2.8 Identification of Cross-linked Peptides
Mass spectrometric raw files were analyzed in Thermo Xcalibur software and 
peptide peaks of interest were picked manually. Mass lists were screened using FindPept 
tool (http://web.expasy.org/findpept/) against enzyme sequences obtained from 
UniProtKB/Swiss-Prot (mMDH: Q32LG3; CS: Q29RK1; ACO: P20004) to identify non­
cross-linked peptides (mass error = 6 ppm). A theoretical mass database of potential inter­
protein cross-links was built up using a spreadsheet by combining two peptides, which 
were identified in native individual enzymes but missed in the cross-linked enzyme 
complex. Additional peptide peaks only found in cross-linked spectra were screened 
against the mass database. Cross-link candidates were selected by the following rules: (1) 
trypsin did not cut at the C-terminus of modified lysines or lysines with proline on the C- 
terminus; (2) up to two missed cleavages were allowed, but nonspecific cuttings were not 
considered; (3) peptide length was 3 ~ 30 amino acids; (4) each cross-linked peptide had 
at least two lysines (one for cross-linking and one at C-terminal); (5) peaks showed up in 
at least duplicate experiments; (6) mass error = 20 ppm. Throughout the whole search 
process, custom-specified modifications were applied and the respective mass variations 
(to residues) were summarized in Table 3.1.
3.2.9 Hybrid Protein Docking
As illustrated in Figure 3.1, global docking and local docking were carried out to 
solve the structure of the mMDH-CS-ACO complex. In global docking, an automated
78
79
Table 3.1 Custom-specific modifications for cross-link identification.
Modification Residue Mass variation (Da)
Acetylation Lysine + 42.011
Oxidation MethionineTryptophan + 15.995
Trimethylation Lysine + 42.047
Phosphorylation Proline + 79.966
C arboxyami domethyl ati on Cysteine + 57.02
Propioamide Cysteine + 71.037
Mono-link (DSG) Lysine + 114.032
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Predicted attracting residues in enzyme-enzyme binding 
based on identified cross-links
>
Global docking by ClusPro 2.0 
with residue constraintst
Totally 100~120 models from 4 docking modes (balanced, 
electrostatic-favored, hydrophobic-favored and 
electrostatic + van der Waals)
>
Evaluation by Xwalk with 
distance constraints
r
Models containing at least two identified cross-links
>
Local docking by Rosetta with 
pre-set binding orientation
t
Top 10 models of lowest energy
Evaluation by Xwalk with 
distance constraints
t
Final model containing most identified cross-links
Figure 3.1 Schematic of the Hybrid Protein Docking.
protein docking web server, Cluspro (http://cluspro.bu.edu/), was utilized. Cross-linked 
lysines identified from manual search were set as attracting residues. All proteins were 
treated as rigid bodies with their “open” conformations obtained from crystal structures. 
Initial approximation based on surface shape complementarity gives 1010 putative complex 
structures, top scoring 20000 o f them being filtered by desolvation and electrostatic 
energetics to give 500 structures of lowest desolvation free energy and 1500 structures of 
lowest electrostatic energy. In a landscape o f free energy versus root-mean-square 
deviation of atomic positions (RMSD), native structures always have the highest number 
of “neighbors” (probably of structural similarity) clustering around. Therefore, the 2000 
candidate structures were valued by moving one of the two proteins around binding sites 
to achieve a free energy map of all subsequent structures. Most promising global candidates 
were selected as their cluster radius was no more than 9 A by default.21-24
Prior to local docking, all model candidates were screened by Xwalk software 
suite25 to filter out false positives of global candidates by distance constraints. Maximum 
Euclidean distance limit was set to 25 A, which is a combination of DSG spacer arm length 
(7.7 A), lysine side chain length (6 A x 2) and backbone flexibility. In addition to Euclidean 
distance limit, solvent accessible surface (SAS) distance was also set to 30 A, to mimic 
molecular flexibility of DSG when cross-linking two residues without penetrating protein 
surface. Solvent radius was 1.4 A by default and set to 2 A for SAS distance calculation. 
Rotamers were removed and only the distance of CP-CP between two lysines was 
calculated.26 A pair of lysines on two proteins in global candidates with their Xwalk- 
calculated separation no more than the limits were considered as a potential cross-link.
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After distance filtering, global candidates bearing at least two potential cross-links 
were subject to local docking accomplished by another protein docking web server, Rosetta 
(http://rosie.rosettacommons.org/) . Starting with the given globally docked structure, the 
program calculated interface energies (versus RMSD) of 1000 possible relative 
conformations at binding sites.27-29 Derived from each starting global structure, 10 local 
candidates of lowest interface energy were screened again by Xwalk. Final complex 
structures were chosen based on two criteria: (1) local candidates of lowest interface energy 
were clustered around a single position on the energy landscape and (2) the structure had 
most potential cross-linkers in agreement with experimental results. Interfacial residues in 
final structures were determined when the measured Euclidean distance was less than 20
A.
3.2.10 Simulation of Surface Electrostatic Potential
Prior to simulation, .docked structures were modified by PDB2PQR web server 
(http://nbcr-222.ucsd.edu/pdb2pqr 2.0.0/) to add missing hydrogens and/or heavy atoms 
and estimate their titration states. Protein complexes were protonated with favorable 
hydrogen bonds. Charges and radius were assigned from Amber force field.30,31 PROPKA 
was used to predict pKa shifts in complexes at pH 7.8, which is the pH of mitochondrial 
matrix32,33. Calculation of surface ESP by Possion-Boltzmann equation was done by APBS 
web server (http://www.poissonboltzmann.org/docs/apbs-installation/) with the following 
parameter settings: (1) water molecules were not removed; (2) no additional ions were 
added; (3) biomolecular dielectric constant was set at 2; and (4) solvent dielectric constant 
was set at 78.54.34
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3.2.11 Graphic Preparation
All figures of protein structures and visualization of surface ESP were made in 
Chimera obtained from www.cgl.ucsf. edu/chimera/.
3.3 Results and Discussion
3.3.1 Separation of the Cross-Linked TCA Cycle Metabolon
Treatment of intact mitochondria with a membrane-permeable cross-linker fixes 
matrix proteins to membrane proteins. As a result, an increased amount of matrix proteins 
would sediment with broken membrane fractions in large aggregates during differential 
centrifugation and hydrophobicity-mediated precipitation. After centrifugation, much 
lighter yellowish color and lower protein amount were observed in the supernatant of cross­
linked sample than non-cross-linked one, implying significant loss of soluble proteins. In 
order to enrich the TCA cycle enzymes still soluble in the supernatant, gel-based separation 
was chosen instead of chromatographic separation to avoid further protein loss and 
dilution. Since all of the samples were treated with a reducing agent, dithiothreitol (DTT), 
protein oligomers or complexes dissociated upon cleavage of intrinsic disulfide bonds 
unless they were cross-linked. As shown in Figure 3.2, in the lane where non-cross-linked 
sample was applied, a set of discrete subunit/small protein bands formed below 100 kDa. 
In the cross-linked lane, these bands were faint or disappeared whereas the region above 
100 kDa became darker and bands smeared, indicating formation of large protein 
complexes. Previously D ’Souza et al. had detected specific activities of mMDH, CS and 
FUM in the starting well after in vivo cross-linking, suggesting that the resultant TCA cycle 
complex was too huge to migrate through the gel pores.35 In our experiment, we also found 
that additional intense protein bands appeared at the top of the gel just near the well. Based
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Figure 3.2 Reducing SDS-PAGE of cross-linked and native (non-cross-linked) 
mitochondrial supernatant. Bands in black squares were cut for digestion and mass 
spectrometric analysis.
on the assumption that the TCA cycle metabolon is over 8000 kDa36, those top bands were 
cut for in gel digestion and LC-MS/MS analysis. The top region of the same location in the 
non-cross-linked lane as well as individual subunit bands were also analyzed as the native 
control.
3.3.2 Identification of the Cross-Linked TCA Cycle Metabolon
As listed in Table 3.2, only mMDH and CS were present in the non-cross-linked 
band, indicating dissociation of the metabolon but a relatively stronger interaction between 
these two enzymes. After cross-linking, all of the TCA cycle enzyme components were 
identified with at least one tryptic peptide matching the database, which confirms again the 
existence of the metabolon. As mentioned in Chapter 1, SDH is also the complex II of the 
ETC in the inner mitochondrial membrane and anchors the rest of the TCA cycle to the 
membrane surface. Cross-linking of SDH to its neighbors in the TCA cycle and ETC, led 
to their co-precipitation during centrifugation and ammonium sulfate precipitation. 
According to the supramolecular model of the TCA cycle metabolon proposed by 
Lyubarev and Kurganov, the aKGDH complex acts as the nucleus surrounded by SCS and 
FUM, followed by assembly of mMDH, CS, ACO and ICDH at the outer shell.36 Trypsin 
digestion might be less efficient in the core of the giant complex, causing missed detection 
of enzyme peptides. In consequence, much fewer tryptic peptides of SDH, FUM, SCS and 
KDH were found matching the database.
3.3.3 Structural Modeling of the mMDH-CS-ACO Complex
In search of potentially conjugated lysines, cross-linking induced additional peptide 
peaks were compared to a manually generated theoretical mass library for all possible 
combinations between available mMDH, CS and ACO peptide fragments. As shown in
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Table 3.2 Identified TCA cycle enzymes in SDS-PAGE bands.













Figure 3.3, there is a complex cross-linking network after the initial search. However, it 
should be kept in mind that the majority of these peaks actually came from other proteins, 
and cross-linking would not likely occur at some lysine residues inaccessible to solvent. 
Despite inter-protein cross-linker, there could be DSG “loops” in the same chain or “dead 
ends” with one end simply hydrolyzed.
With the distance constraints on noted lysine residues in Figure 3.3, docking of 
PPIs in the mMDH-CS-ACO complex was conducted in a rational manner. CS homodimer, 
the biggest of the three enzymes, was set as the receptor during modeling. Prior to docking, 
mMDH was allowed to explore the entire surface of CS in the absence of ACO until a 
model was found to satisfy the distance requirement. As shown in Figure 3.4C, mMDH- 
CS complex turns out to be asymmetric, which is quite different from the symmetric 
quinary model proposed by Srere et al.17 In this complex, both subunits of mMDH bind to 
one side of CS. A long a-helix in CS from Ser2 to His28 is buried in the interface that lies 
across the intersubunit domain of mMDH. N- and C-terminus in one of CS subunits and 
one C-terminal of mMDH are found located next to binding interface, but they are still in 
the open space and accessible to solvent and cross-linkers. Three cross-links were 
identified between mMDH Lys300, Lys304 and CS Lys432, Lys437. The two N-terminus 
of mMDH are far from the binding interface and faces the opposite direction. Distance 
measurements revealed the following interfacial residues: mMDH Ile34-Pro38, Tyr56-60, 
Gly77-Thr95, Lys215-Ala220 and CS Ser2-His28, Ser424-Lys437.
Docking ACO to CS was performed in the presence of mMDH. As indicated by 
protein identification, CS has stronger affinity for mMDH than for ACO. Therefore, the 
presence of mMDH may affect ACO’s exploring the surface of CS. Assuming that the
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Figure 3.3 Network of cross-link candidates in mMDH-CS-ACO complex.
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Figure 3.4 Two models, MCA1 (A) and MCA2 (B) of mMDH-CS-ACO complex and 
model of mMDH-CS complex in the absence of ACO (C). The two chains of CS are 
colored in goldenrod and khaki. The two chains of mMDH are colored in sky blue and 
cyan. Monomeric ACO is colored in plum. Identified cross-links are represented by red 
bars with linked lysine residues numbered.
stoichiometric ratio was 1:1:1, we proposed two models for the mMDH-CS-ACO complex. 
As illustrated in Figure 3.4A, ACO binds the same CS subunit as mMDH does and its C- 
terminal extends into the inter-subunit pocket of CS. Four cross-links were identified 
between ACO Lys30, Lys201, Lys709 and CS Lys294, Lys300. There is another 
possibility that ACO and mMDH are located on opposite sides (MCA2), as shown in Figure 
3.4B. Change of position does not cause increased separation of mMDH and ACO. On the 
contrary, their distance is dramatically shortened and the closest amino acids are within 
only 15 A. Enhanced association between mMDH and ACO, however, led to a slightly 
loosened connection between CS and ACO. Only two cross-links were identified between 
ACO Lys30, Lys709 and CS Lys294, Lys300. Nonetheless, in both models, the C-terminus 
as well as the following regions of ACO were found to interact with the same amino acids 
of CS: ACO Asp48-Glu54, Phe544-Asp551, Leu702-Ala706, Glu733-Lys754, and CS 
Arg195-Ser199, Gly218-Asp221, Thr286-Val296, Pro342-Pro345, Gly218-Asn391. 
However, no potential cross-links between mMDH and ACO were identified in either 
MCA1 or MCA2.
Forming complexes definitely brings enzyme active sites in close proximity, 
reducing diffusion lengths for substrates. As shown in Figure 3.5, the average distances 
between active sites are about 35 A for mMDH-CS and 50 A for ACO-CS in MCA1. 
Docking mMDH and ACO onto different subunits of CS resulted in increased active site 
separation to 65 A for ACO-CS, and it seems less favorable for efficient substrate transport 
than MCA1 where mMDH and ACO are separated by only one active center. Comparing 
the binding surface areas (buried solvent accessible areas), MCA1, which has 10000 A2 for 
mMDH-CS and 13000 A2 for ACO-CS is more thermodynamically favorable than MCA2,
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Figure 3.5 Active sites (red spheres) in MCA1 (A) and MCA2 (B): mMDH Ile12, Arg80, 
Arg86, Asn118, Arg152 and His 176;37 CS His238, Asn242, His 274 and Arg401;38 ACO 
His101, Asp165, Ser166, His167, Cys358, Arg447, Arg452, Ser642, Ser643 and Arg644.39 
which has 10000 A2 for mMDH-CS and 12000 A2 for ACO-CS.
red dashed line represents the Euclidean distance. Meshed surface of the complex was 
created in Chimera.
3.3.4 Electrostatic Channeling in the mMDH-CS-ACO Complex
A theoretical study done by Elcock and McCammon demonstrated that the presence 
of surface electrostatic forces resulted in one order of magnitude increase in substrate- 
transport efficiency, while less than 1% of molecules were directly transported without 
electrostatic forces.40 In this work, simulation of the surface electrostatic potentials of the 
metabolon structures proved the charge rearrangement and electrostatic channeling 
formation upon protein-protein association. As illustrated in Figure 3.6, free CS is slightly 
negatively charged at pH 7.8, but an area of positive potential extends from the inside of 
the cleft where the active sites are located to the outer surface. Similar positively charged 
patterns are found at active site regions in free mMDH and ACO. This will definitely help 
accommodate carboxylate substrates (L-malate, OAA and citrate) into the right place. In 
the unbound state, most of the enzyme surface stays nearly neutral. In the complex, these 
positively charged patterns get expanded across binding interfaces and interconnected to 
form a continuous band (channel) linking active sites. In the meantime, negatively charged 
patterns have also been rearranged to cover regions next to the “positive channel”. This 
change seems to make the enzyme surface more “polarized” with electrostatic 
complementarities maintained. Under combined effects from electrostatic attraction and 
repulsion, charged intermediates would be microcompartmentalized, and their transport on 
enzyme surface might be restricted to the electrostatically favored path. It has been noticed 
that regions participating in the interface formation are mainly nonpolar and hydrophobic, 
which might also facilitate redistribution and connection of charged patterns. Thus, it can
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mMDH CS CS ACO
+5 kT 0 kT -5 kT
Figure 3.6 Illustration of surface ESP in MCA1 and free enzymes at pH7.8. Active sites 
are denoted by orange arrows and electrostatic channels are highlighted by yellow edges. 
Negatively charged, positively charged and neutral regions are colored in red, blue and 
white.
be seen that the formation of substrate channeling in metabolons may be an outcome of 
complex balancing of both electrostatic and hydrophobic interactions.
3.3.5 Symmetric Model of the mMDH-CS-ACO Complex
Finally, we constructed a higher-ordered model for the mMDH-CS-ACO complex 
based on MCA1. As shown in Figure 3.7, the central core, the CS dimer, is surrounded by 
two mMDH dimers and two ACO monomers. Each asymmetric subunit, composed of one 
CS subunit, one mMDH dimer and one ACO monomer, is symmetric to the other, making 
the octamer a two-fold symmetry.
3.4 Conclusions
In this chapter, the existence of the TCA cycle metabolon has been experimentally 
demonstrated by identifying all of the eight enzymes through in vivo cross-linking and 
mass spectrometry. Using distance constraints derived from cross-links, two models for the 
wild-type mMDH-CS-ACO complex were proposed, and a two-fold symmetric octamer 
has been constructed by two mMDH dimers, one CS dimer, and two ACO monomers. 
Analysis of surface electrostatic potential of the model shows that rearrangement of surface 
charge patterns upon protein-protein association leads to forming a continuous positively 
charged zone across their interface. This would consequently facilitate directed transport 
of carboxylate substrates from one active site to the next. Until this work, direct observation 
of substrate channeling remained a big hurdle in metabolon research, even though 
simulation work has built a theoretical foundation for its metabolic implications. This 
investigation of natural TCA cycle metabolons gains structural insight into the organization 
of wild-type enzymes within the mitochondrial matrix, and provides an orientation option 
(MCA1) for engineered TCA cycle metabolon to achieve substrate channeling in vitro.
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Figure 3.7 Two views of the octamer of the mMDH-CS-ACO complex. Top: 2-fold 
symmetry axis is parallel to the plane and passes through the center of CS dimer. Bottom: 
2-fold symmetry axis is perpendicular to the plane and points from the center of CS dimer.
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CHAPTER 4
CHARACTERIZATION OF POLYMERIRC CO-IMMOBILIZATION OF THE TCA 
CYCLE ENZYMES USING FORSTER RESONANCE ENERGY TRANSFER
4.1 Background Introduction
4.1.1 Foster Resonance Energy Transfer
Forster resonance energy transfer (FRET) is a nonradiative energy transfer between 
a donor fluorophore and a nearby acceptor, a part of whose absorption spectrum overlaps 
with the donor emission spectrum. As illustrated by the Jablonski diagram (Figure 4.1), 
electronically excited donor molecules tend to return to the ground states by releasing extra 
energies through fluorescent emission or non-radiative decay. Long range dipole-dipole 
interactions can cause the intermolecular energy transfer from the excited donor to the 
acceptor at the ground state without emitting photons. As a result, the fluorescence o f the 
donor fluorophore is quenched and its emission intensity decreases. In the meantime the 
excited acceptor may release photons o f lower energies in terms o f another emission peak 
at longer wavelengths. FRET efficiency (E) is defined as the extent of donor excitation 
energy transferred to the acceptor, and dependent on (1) spectrum overlap integral between 
donor emission and acceptor absorption spectra (J(^)), (2) donor-acceptor distance (r), (3) 
relative orientation factor of donor and acceptor transition moments ( k  2), (4) donor 
quantum yield ( Q d ) ,  and (5) lifetim e of donor ( t  d ) .  Given donor emissive rate
Reprinted from “Wu, F., Minteer, S. D. Biomacromolecules 2013, 14, 2739” with permission from the American Chemical Society
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Figure 4.1 Jablonski diagram of fluorescence emission (Fd and rA), non-radiative decay 
(knr(D) and knr(A)) and FRET (kT).
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(Td), donor non-radiative decay rate (knr(D)) and energy transfer rate (kT), E is calculated by
and defining the Forster distance, which is a characteristic distance of a specific donor- 
acceptor pair
It can be seen that the extent of energy transfer is directly linked to the spatial separation 
between donor and acceptor. Because the FRET efficiency can be obtained from measured 
fluorescence intensity in steady-state experiment or fluorescence lifetime in time-resolved 
experiment, one can determine the distance between donor and acceptor, which is of great 
significance to studying interactions or spatial organization of biomacromolecules.1
4.1.2 Photobleaching FRET Imaging
Photobleaching refers to destroying fluorophores by repeated excitation. This 
process is irreversible and results in partial or complete loss of fluorescence. In a FRET 
system, photobleaching of the donor or acceptor quenches energy transfer and reduces
kf
r D+knr(D) +kT
Taking into account that
where n is the refractive index of the medium, then




FRET efficiency. When the donor is photobleached, sensitized acceptor fluorescence 
intensity will decrease or be eliminated. When the acceptor is photobleached then quenched 
donor fluorescence will get recovered. In studying biomacromolecules in cells or 
immobilized onto a substrate or scaffold by FRET imaging, it is always difficult to 
calculate FRET efficiency from averaged fluorescence intensities when fluorophores are 
not uniformly distributed. Self-quenching also interferes with the accurate measurement of 
FRET efficiency. Therefore, photobleaching FRET imaging is exploited to rule out the 
effect of self-quenching and enable an in situ analysis of emission intensities of the 
fluorophore before and after its FRET partner being destructed, usually by a high-power 
laser beam or long exposure to laser scanning.2
4.1.3 Polymeric Co-Immobilization of Enzyme Cascade
Studies have shown that cytoskeleton in cytoplasm and organelles provides 
metabolic organization with a favorable microenvironment enhancing both protein-protein 
and protein-scaffold interactions.3 As a matter of fact, diffusivity of metabolic enzymes is 
remarkably reduced in such “polymeric” medium4, and metabolons are associated to 
structural elements in vivo, such as lipid membrane, actin and microtubule.3 In vitro, 
researchers have also demonstrated immobilization-enhanced protein-protein interactions 
and coupled activities in polymer matrices.5 Early in 1970s, Mattiasson et al. observed an 
increase in coupled catalytic rate of a two-enzyme cascade in PEG solution.6 Srere et al. 
reported an activity and kinetic promotion of a three-enzyme system entrapped in cross­
linked polyacrylamide gels.7 Up to now, a variety of polymer families and immobilization 
techniques have been developed for assembling enzyme cascades. Generally, multiple 
enzymes may be attached to polymer matrices through absorption, covalent conjugation,
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electrostatic attraction, or hydrophobic interaction, or by encapsulation in micelles or 
polymersomes. Hence, polymers are modified to meet different immobilization goals. 
Functional groups are added to achieve covalent polymer-enzyme linkages. Side chains are 
made polar or charged to enhance hydrophilic or ionic interactions. Hydrophilic polymer 
backbones can be tailored by alkyl chains as to introduce the amphiphilicity, which is 
believed to be a nontrivial environmental factor in stabilizing metabolons. Then it is not 
surprising to see the improvement of multienzyme association in hydrophobically modified 
polymer matrices.8,9
4.1.4 Hydrophobic Modification for Co-Immobilization of the TCA Cycle Cascade
In this work three types of polymers are investigated for co-immobilization of a 
three-enzyme system: polyethyleneimine (PEI), Nafion (NF) and chitosan (CHIT). All of 
them are commonly used for BFC fabrication due to their open accessibility for chemical 
modification and good compatibility with enzymes and electrodes.
4.1.4.1 Polyethyleneimine. PEI is a water-soluble polyamine that can associate 
tightly to negatively charged residues and form PEI-protein complexes. Secondary amines 
in linear PEI (LPEI) are very reactive, enabling modifications by various reagents. 
Ethylene glycol diglycidyl ether (EGDGE) has been frequently used in creating a cross­
linked, robust LPEI hydrogel. LPEI can also be alkylated by halogenoalkane through 
nucleophilic substitution. For instance, reaction with 1-bromooctane attaches an octyl alkyl 
chain to the backbone secondary amine and yields C8-LPEI.10,11
4.1.4.2 Nafion. Nafion is a perfluorinated cation-exchange polymer which is widely 
used for electrochemical applications.12 Once cast, Nafion membrane is constructed by the 
hydrophobic fluorocarbon backbone, the hydrophilic ionic clusters o f sulfonic acid groups
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and the interfacial space.13 When treated with alkylated phosphonium or quaternary 
ammonium salts, Nafion will exchange protons at the sulfonic acid sites for the alkylated 
phosphonium or ammonium ions, which then changes the size of its micellar structures. 
Moreover, neutralization by alkylation makes the polymer more compatible to
12,14enzymes.1A
4.1.4.3 Chitosan. Chitosan is a polysaccharide derived from chitin which is found 
abundant in nature.15 Similar to PEI, chitosan also interact with negatively charged species 
when its primary amines in the backbone are protonated, which makes the polymer a good 
protein-precipitating reagent. On the electrode, it can form a macroporous 3D scaffold that 
allows much faster mass transport from bulk solution to the electrode. By attacking the 
primary amine with aldehydes, alkyl chains of different lengths can be tailored to the 
hydrophilic backbone of chitosan. This will not only prevent extensive conjugation or 
precipitation during immobilization, but also introduce an amphiphilic microenvironment 
for enzymes.16,17
4.1.5 Aims
Martin et al. demonstrated that immobilization can induce homo-aggregation of 
mMDH and hydrophobic modification would increase the degree of enzyme aggregation 
in polymers.9 This then led to the question that whether hetero-aggregation of multiple 
enzymes can also be enhanced by hydrophobic modification. In order to explore the 
relationship between spatial organization of enzymes and the microstructure of polymers, 
the acceptor photobleaching FRET imaging technique was applied in assessing the 
separation of mMDH, CS and ACO, which were co-immobilized in LPEI, NF, and CHIT 
as well as their hydrophobically modified derivatives (structures shown in Figure 4.2).
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Figure 4.2 Polymer structures: (A) LPEI, (B) C8-LPEI, (C) NF, (D) tetrabutylammonium 
(TBAB) NF, (E) trimethyloctylammonium (TMOA) NF, (F) 
trimethyloctadecylammonium (TMODA) NF, (G) CHIT, (H) butyl-modified CHIT (BU- 




AlexaFluor® 488 and AlexaFluor® 555 labeling kits were purchased from 
Invitrogen (Life Technologies). Potassium phosphate was purchased from EMD Chemicals. 
Sodium phosphate was purchased from Mallinckrodt Baker. Sodium hydroxide and 
potassium hydroxide were purchased from Macron Chemicals. NAD+ was purchased from 
Research Products International. Mitochondrial MDH, CS, ACON and all other chemicals 
were purchased from Sigma-Aldrich unless otherwise stated.
4.2.2 Preparation of Polymers
Octyl-modified linear polyethyleneimine polymer was synthesized from stock 
linear polyethyleneimine in the lab using the procedure reported by Moehlenbrock et al.10 
(yield: 95%). The chitosan polymers were deacetylated before further modification through 
the autoclaving method developed by Sjoholm et al.18 (yield: 85%). The butyl-modified 
chitosan was prepared according to the procedure described by Klotzbach et al.1  (yield: 
94%). The a-linoleic acid-modified chitosan was prepared according to the procedure 
described by Martin et al.19 (yield: 60%). Nafion polymers were modified according to the 
procedure from Watt et al.20 (yield: 80%).
4.2.2 Fluorescent Labeling of Enzymes
Enzymes were fluorescently labeled as described in Chapter 2 with some 
modifications. Two milligrams of CS (or mMDH) was dissolved in 1 mL of 100 mM 
potassium phosphate (pH 7.5) buffer and mixed with one vial of AlexaFluor® 488 (or 
AlexaFluor® 555). A 100 |iL aliquot of 1 M sodium bicarbonate (pH 9.0) was added to 
increase the reaction pH to ~8.3. Two milligrams of ACON powder was suspended in 1
mL of 50 mM sodium phosphate buffer (pH 8.3) and mixed with one vial of AlexaFluor® 
488. All of the mixtures were incubated in the dark at room temperature for 1 h and then 
at 4 °C for 24 h to allow the conjugation between dyes and primary amines of lysine 
residues. Unreacted dyes were removed from labeled enzymes through overnight dialysis 
against 1 L of 50 mM Tris buffer (pH 7.4) at 4 °C, followed by a series of dialysis in 500 
mL volumes for 2 to 3 h until their steady-state polarization measured with a fluorescence 
spectrophotometer (F-7000, Hitachi) remained unchanged (0.20 ~ 0.30). Then, the 
concentrations of dyes were determined by measuring the UV absorbance of AlexaFluor® 
488 at 494 nm (extinction coefficient is 71000 cm-1M-1) and of AlexaFluor® 555 at 555 nm 
(extinction coefficient is 150000 cm-1M-1) in a UV-vis spectrophotometer (Evolution 260 
Bio, Thermo Scientific). Assuming that no significant amount of enzymes was lost during 
dialysis, the final dye to enzyme molar ratio was about 1:1. This ratio was controlled to be 
low to avoid possible interference from attached dyes to enzyme-enzyme interactions. All 
labeled enzymes were stored in 100 mM potassium phosphate buffer (pH 7.5) in the dark 
at -20 °C before use.
4.2.3 Immobilization of Labeled Enzymes
Six different mMDH/CS/ACON solutions were prepared by mixing equal volume 
of enzyme stock solutions (5 mg/mL for each enzyme). The solutions were: AlexaFluor® 
488-labeled mMDH mixed with nonlabeled CS and ACON (488-mMDH/CS/ACON, 
Solution I), AlexaFluor® 488-labeled ACON mixed with nonlabeled mMDH and CS 
(mMDH/CS/488-ACON, Solution II), AlexaFluor® 555-labeled CS mixed with 
nonlabeled mMDH and ACON (mMDH/555-CS/ACON, Solution III), AlexaFluor® 488- 
labeled mMDH and AlexaFluor® 555-labeled CS mixed with nonlabeled ACON (488-
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mMDH/555-CS/ACON, Solution IV), AlexaFluor® 488-labeled ACON and AlexaFluor® 
555-labeled CS mixed with nonlabeled mMDH (mMDH/555-CS/488-ACON, Solution V), 
and mixture of nonlabeled mMDH, CS and ACON (mMDH/CS/ACON, Solution VI). 
Thirty microliters of each mMDH/CS/ACON solution was mixed with each polymer 
solution (20 |iL of 1% CHIT or BU-CHIT or ALA-CHIT solution, 7.5 |iL of 10 mg/mL 
NF or TBAB-modified NF or TMOA-modified NF or TMODA-modified NF suspension, 
or 7.5 |iL of 10 mg/mL LPEI or C8-LPEI suspension) at an enzyme/polymer molar ratio 
of about 2:1 to a final volume of 50 L, separately. Ten microliters of each enzyme/polymer 
suspension was drop-cast onto a microscopic cover glass slide (VWR) and dried at room 
temperature overnight. All fluorescent slides were stored in dark at 4 °C before use.
4.2.4 Fluorescent Imaging of Labeled Enzymes in Polymer Films
The fluorescent slides were imaged using a Nikon AIR laser scanning confocal 
microscope with a 20X objective. For regular images, samples were excited at 488 and 561 
nm. For FRET images, samples were excited only at 488 nm. Two emission band filters 
(515/30 and 595/50) were used to detect the location of donors and acceptors in the 
polymers, respectively.
4.2.5 Steady-State FRET Spectroscopy
The emission spectra o f labeled enzymes immobilized in polymers were collected 
by the fluorescence spectrophotometer. All slides were excited at 488 nm and fixed in a 
surface sample holder at an angel of 30° to minimize excitation light scattering. Each 
spectrum was collected from three scans on the same slide. Triplicate measurements on 
different slides were performed to generate the average emission spectrum. Nonlabeled 
slides (made from Solution VI) were scanned for background correction.
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4.2.6 Acceptor Photobleaching FRET Imaging
The acceptor photobleaching was performed with the Nikon AIR laser scanning 
confocal microscopy by exposing the sample slides to a repeated excitation at 561 nm at 
its maximum power for 3 min. The time required for photobleaching was previously 
determined so that over 60% of acceptors were destroyed while unwanted bleaching of 
donors was minimized. Regular images and FRET images were collected before and after 
the photobleaching. Donor-only-labeled slides (I and II) were imaged for donor 
photobleaching correction. Acceptor-only-labeled slides (III) were imaged for acceptor 
cross-talk and bleaching photoproduct correction. Nonlabeled slides (VI) were imaged for 
background subtraction. FRET data were collected from three different photobleached 
regions on the slides.
4.2.7 FRET Calculations
Steady-state FRET efficiency, Ess, was given by1
FD-FDA f da 
Ess= ^-----= 1-_T~f D f d
where FD and FDA are the fluorescence intensities of the donors in the donor-only-labeled 
slides and double-acceptor-labeled slides, respectively. The average donor-acceptor 
separation, rss, was given by1
1/6
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£ - 0rss=R0 \Ess
For AlexaFluor®488- AlexaFluor®555, Rq is 7.0 nm.
For the acceptor photobleaching results, all images for FRET data analysis were 
processed using the program ImagJ with a Java-built AccPbFRET plugin developed by
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Roszik et al.21, including image registration, background subtraction, image calculation 
and measurement. The pixel-by-pixel FRET efficiency, Epb(i;j), was determined by
intensity of the same pixel before photobleaching. a, y, 5 and s are the acceptor partial 
photobleaching, donor photobleaching, acceptor crosstalk and acceptor bleaching 
photoproduct correction factors, respectively. The detailed procedure for determining all
4.2.8 Immobilized Enzyme Activity Assay
Diluted nonlabeled mMDH/CS/ACO solution was prepared by mixing equal 
volume of stock enzyme solutions (1 mg/mL). Sixty microliters of the enzyme solution 
was mixed with 40 ^L of polymer suspension to an enzyme/polymer molar ratio of 1:2. 
After the sample was thoroughly mixed, a 90 ^L aliquot was drop-cast onto the bottom of
E = 1  ___________  v ___________
pb('J) - T(F°D20J)-(a5+(1-a)s)FAKij))-a(FDKij,-5FA10j))
(1-a)(FDi(iJ)-5FAicJ))
where FD1(i,j) and FD2(i,j) are the uncorrected donor fluorescent intensities of the pixel (i, j) 
before and after photobleaching while FA1(i,j) is the uncorrected acceptor fluorescent




by plugging in FD1(i,j)=FD1(i,j)-5FA1(i,j) 
and FD2(i,j)=y(FD2(i,j)-(a5+(1-a)s)FA1(i,j))
The pixel-by-pixel donor-acceptor separation, rpb(i,j), was given by
the disposable cuvette and dried at 4°C overnight. A 100 p,L aliquot of the activation 
reagent (made by mixing 4 mL of 100 mM potassium phosphate buffer, 100 p,L of 1 mM 
Fe(NH4)2(SO4)2 and 200 p,L of 50 mM L-cysteine) was added to activate ACO at 0°C for 
1 h. Then a reaction cocktail composed of 50 ^L of 0.5 mM acetyl-CoA, 250 ^L of 50 mM 
P-NAD and 600 p,L of 100 mM L-malate was added for the enzyme activity assays. All 
assay solutions were adjusted to pH 7.5. The UV absorbance at 340 nm, corresponding to 
the production of NADH, was recorded using a UV-Vis spectrometer every 1 min over a 
5 min interval for calculating specific activities.
4.3 Results and Discussion
4.3.1 Co-Localization of mMDH, CS and ACO
Immobilized enzymes were once assumed to co-disperse throughout the polymer 
matrix uniformly. However, Konash et al. showed that enzyme distribution in solid-state 
polymer films was highly heterogeneous and reported discrete enzyme aggregates in 
polymer films22. The three enzymes might be co-localized to form metabolon or undergo 
homo-aggregation to form higher-ordered oligomers observed by Martin et al.9. 
Oligomerization may occur when transiently unfolded proteins precede self-assembly of 
polypeptide chains.23 Hence, in different polymer media, the equilibrium between the 
unfolded and folded states of enzymes could shift, thereby resulting in different extent of 
oligomerization. By profiling the donor and acceptor fluorescence intensities along the 
diagonal line of each focal plane, we could qualitatively compare the degree of enzyme co­
localization and self-aggregation.
As shown in Figure 4.3, most enzymes self-aggregated in both LPEI and C8-LPEI. 
This is indicated by peaks at 50 p,m ~ 70 p,m from 488-mMDH/555-CS in LPEI and peaks
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488 mMDH/555-CS 488 ACO/555-CS
Figure 4.3 Merged fluorescence microscopic images of enzymes in LPEI (A) and C8-LPEI 
(B). 488 nm-excited donors (CS) are in green pixels) and 561 nm-excited acceptor 
(mMDH or ACO) are in red pixels. Intensity profiles on the right are achieved by plotting 
the grey values of 488-mMDH (blue solid), 488-ACO (green solid) and 555-CS (red 
solid) at each pixel along the diagonal line.
at 80 p,m ~ 113 p,m and 200 p,m ~ 240 p,m from 488-mMDH/555-CS in C8-LPEI. Large 
isolated clusters formed possibly due to enzyme-polymer backbone conjugation. On the 
other hand, Nafion polymers showed improved capability for enzyme immobilization. 
Highly overlapped emission spectra of donors and acceptors in all NF slides (Figure 4.4 
and 4.5) implied the enzyme co-localization, although there was still some degree of self­
aggregation in TMOA-NF. As good protein precipitating reagents, chitosan polymers can 
also conjugate tightly with enzymes, but unlike LPEI and C8-LPEI, we observed the co­
immobilization of enzymes on a scaffold-like matrix (Figure 4.6) in either native chitosan 
polymer (CHIT) or modified chitosan polymer (BU-CHIT and ALA-CHIT). Compared to 
the other two, the network in ALA-CHIT was much denser and fewer intense clusters were 
seen in the images. According to intensity profiles, NF and CHIT polymers turned out to 
be a better immobilization platform for inducing enzyme co-localization than LPEI and 
C8-LPEI polymers, in which resulted enzymes were self-aggregated.
4.3.2 Multienzyme Aggregation State of mMDH/CS/ACO
Figure 4.7 illustrates the absence of FRET in single-type enzyme aggregates and 
occurrence o f FRET caused by co-aggregation. Using steady state emission scan, we 
determined the multienzyme aggregation state in terms o f average protein separations 
between donors and acceptors, which are summarized in Figure 4.8. Comparing LPEI and 
C8-LPEI slides, we did not find statistical differences in enzyme separations upon 
hydrophobic modification, which can be explained by extensive self-aggregation and 
polymer-enzyme conjugation in LPEI hydrogels. In Nafion polymers, it is significant that 
the separation decreased from plain NF to TMOA-NF. This is in agreement with why the 
encapsulation capability is improved greatly in TMOA modified Nafion, whose micelle
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488 mMDH/555-CS 488 ACO/555-CS
Figure 4.4 Merged fluorescence microscopic images of enzymes in plain NF (C) and 
TBAB-NF (D). 488 nm-excited donors (CS) are in green pixels) and 561 nm-excited 
acceptor (mMDH or ACO) are in red pixels. Intensity profiles on the right are achieved by 
plotting the grey values of 488-mMDH (blue solid), 488-ACO (green solid) and 555-CS 
(red solid) at each pixel along the diagonal line.
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488 mMDH/555-CS 488 ACO/555-CS
Figure 4.5 Merged fluorescence microscopic images of enzymes in TMOA-NF (E) and 
TMODA-NF (F). 488 nm-excited donors (CS) are in green pixels) and 561 nm-excited 
acceptor (mMDH or ACO) are in red pixels. Intensity profiles on the right are achieved by 
plotting the grey values of 488-mMDH (blue solid), 488-ACO (green solid) and 555-CS 
(red solid) at each pixel along the diagonal line.
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Figure 4.6 Merged fluorescence microscopic images of enzymes in native CHIT (G), BU- 
CHIT (H) and ALA-CHIT (I). 488 nm-excited donors (CS) are in green pixels) and 561 
nm-excited acceptor (mMDH or ACO) are in red pixels. Intensity profiles on the right are 
achieved by plotting the grey values of 488-mMDH (blue solid), 488-ACO (green solid) 
and 555-CS (red solid) at each pixel along the diagonal line.
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Figure 4.7 An illustration of self-enzyme aggregation and multi-enzyme aggregation 
induced by co-immobilization in polymers.
118
Figure 4.8 Calculated average enzyme separations from steady-state FRET efficiencies. 
mMDH-CS distances are represented by blue columns and CS-ACO distances are 
represented by green columns with standard deviations (error bar).
diameter was estimated to be more than 10 nm, compared to plain NF (~4 nm) and TBAB- 
NF (~6.5 nm).24 Larger micelle size enables capture of larger enzymes, like ACO and CS, 
thereby facilitating the interaction between multiple partners. The situation is different in 
TMODA-NF, because no discernible micellar structures form as previously reported24, so 
the encapsulation effect became trivial during immobilization and the separation increased 
slightly compared to TMOA-NF. In CHIT polymers, the trend was reversed, that is, the 
separations being larger in BU-CHIT and ALA-CHIT. As mentioned above, chitosan 
polymers can act as the polyconjugational ‘cross-linkers’, leading to formation of a 
stabilized multienzyme network. Hydrophobically modified chitosan polymers did not 
work as expected in increasing co-aggregation state, which is likely due to reduction of 
available ionic sites in the backbone of the polymer after alkylation.
4.3.3 Distribution of Distances in mMDH/CS/ACO Aggregates
Although we have obtained the average multi-aggregation state, detailed 
organization of enzymes was still unclear due to its heterogeneity throughout the polymer 
matrix. Enzymes might be in closer proximity in some regions than in others. The acceptor 
photobleaching method realized direct investigation of FRET at single sites in a region of 
interest (illustrated in Figure 4.9). By measuring the small increases in intensities from de­
quenched donors, we determined the FRET efficiency at each site by pixel-by-pixel image 
calculations and finally the separation distribution throughout the imaged area. Typical 
image processing is shown in Figure 4.10.
As shown in Figure 4.11, enzyme separations in LPEI and C8-LPEI spanned a wide 
range, which is consistent with our intensity profiling results. Due to the tendency of 
enzymes to self-aggregation in a nonuniform manner, LPEI and C8-LPEI are not good
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D o n o r A c c e p to r
Figure 4.9 An illustration of partial acceptor photobleaching on TBAB-NF film with 488- 
mMDH/555-CS/ACO co-immobilized. Both donors and acceptors were excited at 488 nm.
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Figure 4.10 A set of acceptor photobleaching FRET images. FD1 and FD2 are corrected 
donor images (only excited at 488 nm) before and after bleaching. The FRET efficiency 
map (bottom left) was obtained using imaging calculation (the color bar on top left 
indicates the FRET efficiency) and then protein distance (bottom right) was counted pixel 
by pixel in the 512x512 efficiency image.
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Figure 4.11 Distribution of protein distance between mMDH and CS (blue column) or 
ACO and CS (green column) in LPEI (A) and C8-LPEI (B).
candidates for building up a closely associated three-enzyme system. In NF polymers 
(Figure 4.12), rpb distribution in mMDH/CS/ACO became narrower as the hydrophobicity 
increased. Plain NF has very uniform micellar structures with an average micelle pocket 
diameter of only 4 nm.24 As a result, encapsulation would not be very efficient for all three 
enzymes and only a few mMDH were encapsulated. This might explain why the 
distribution band split (6.8 nm and 7.5 nm) for mMDH/CS and remained as one peak (6.6 
nm) for ACO/CS. After modification with a hydrophobic ammonium cation, the confined 
micellar structure in native NF was altered. In TBAB-NF, the polymer micelles were 
expanded to an average of 6.5 nm.24 The two rpb distribution bands become significantly 
narrower and the split peak (7.5 nm for mMDH/CS in plain NF) disappeared, but their 
average values (6.7 nm for mMDH/CS and 6.4 nm for ACO/CS) did not differ much from 
those in plain NF. In this situation, probably most mMDH were encapsulated while the 
other two were still outside of the micelles. The rpb bands become broader and split again 
in TMOA-NF. Unlike in plain NF, the two peaks for mMDH/CS were positioned at shorter 
distances, 5.5 nm and 6.8 nm. Separation of ACO/CS was distributed around 6.1 nm. As 
previously reported, micelles in TMOA-NF can be classified into three groups by sizes. 
Besides residual unmodified units that form micelles of 4 nm (like in plain NF), there are 
micelles of medium size (~10 nm) and large size (>20 nm).24 Therefore encapsulation of 
one, two or even three enzymes could occur. Although no discernible micellar structure is 
evident in TMODA-NF, enzymes seemed to co-disperse in its matrix, which was supported 
by the fully overlapped narrow r distribution bands around 5.8 nm.
Results from chitosan polymers indicated the tradeoff between ionic binding and 
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Figure 4.12 Distribution of protein distance between mMDH and CS (blue column) or 
ACO and CS (green column) in native NF (C), TBAB-NF (D), TMOA-NF (E) and 
TMODA-NF (F).
enzymes with long fatty acid side chains than butyl modified CHIT, even though BU-CHIT 
was found to be more hydrophobic.19 As shown in Figure 4.13, enzyme distance 
distribution was the broadest in BU-CHIT, averaged around 6.7 nm (for mMDH/CS) and 
7.9 nm (for ACO/CS). Comparing distribution bands in unmodified CHIT and ALA-CHIT, 
they looked very similar in shape but the average distances in native CHIT were a bit 
shorter. This was possibly due to the fact that only a very small fraction of backbone amines 
were substituted by ALA under exploited conditions so that the microenvironment in ALA- 
CHIT did not vary a lot from native CHIT, but the substitution still caused some loss of its 
‘cross-linking’ effect.
It is worth mentioning here that the steady-state FRET and acceptor photobleaching 
FRET were inconsistent on the average protein separation in some polymers. For example, 
r in TMODA-NF is larger than in TMOA-NF using steady-state FRET but smaller using 
acceptor photobleaching FRET. The latter technique should be more reliable in this work, 
because extensive self-aggregation would also cause self-quenching of donors.
4.3.4 Immobilized Single Enzyme Activity
Catalytic performance of immobilized mMDH was evaluated as to compare the 
effect of immobilization on single enzyme activity. In Figure 4.14, there was a clear trend 
showing that enzyme activity increased upon hydrophobic modification of polymers, 
especially NF and CHIT polymers. In plain NF, the sulfonic acid side chain of the polymer 
was fully protonated, which deactivated the enzymes. By replacing the protons with 
alkylammonium, its acidic microenvironment was buffered and deactivation was reduced, 
proved by the drastic increase in activities of enzymes in modified NF. As alkyl chains 
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Figure 4.14 Specific activity of immobilized mMDH in different polymer films.
polymers, the enzyme activity increased consistently from native CHIT to ALA-CHIT. 
Extensive ionic ‘cross-linking’ may block the active sites of enzymes in plain CHIT. Alkyl 
substitution reduced such risk and introduced an amphiphilic microenvironment to improve 
enzyme performance.
4.4 Conclusions
In this chapter, aimed at selecting the suitable polymer materials for co­
immobilization of enzyme cascades, FRET microscopy, especially acceptor 
photobleaching FRET technique, has been shown as a powerful tool in mapping the 
heterogeneous enzyme associations in solid-state matrices, and interactions between three 
TCA cycle enzymes in commonly used polymers for electrode fabrication have been 
quantitatively investigated. Through direct investigation of immobilized enzymes using 
fluorescent imaging, linear polyethylenimine and octyl modified linear polyethylenimine 
have been excluded from potential co-immobilization matrices due to single enzyme self­
aggregation rather than multienzyme complex formation. By measuring the apparent 
energy transfer efficiency with FRET spectroscopy, the average enzyme distances have 
been determined to show that high multienzyme aggregation state (shortest distance) can 
be achieved in TMOA-NF and TMODA-NF. With acceptor photobleaching FRET 
microscopy, TMODA-NF has been demonstrated as the best potential platform for the 
TCA cycle metabolon biomimic with the most uniform enzyme separation among all the 
tested polymers. Although chitosan polymers did not induce much enhancement on 
multienzyme aggregation during FRET experiments, they are still good biocompatible 
templates for further functionalization. Moreover, efficient substrate/product transport
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through the macroporous chitosan scaffolds is another significant advantage in promoting 
sequential catalysis.
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CHAPTER 5
THE ARTIFICIAL TCA CYCLE METABOLON WITH ENHANCED 
SUBSTRATE CHANNELING
5.1 Background and Motivation
5.1.1 Protein Engineering in Artificial Metabolon Design
In designing metabolic compartmentation for in vitro applications, protein 
engineering is advantageous in manipulating the structure and function of enzymes. With 
a variety of engineering strategies reviewed in Chapter 1, different architectures can be 
achieved in artificially assembled enzyme cascades.1-9 Generally, the approach is 
introducing an attachment, substitution, insertion or deletion to the sites of interest in wild- 
type (WT) enzymes through recombinant DNA technology or other sophisticated methods. 
Mutated enzymes are then scaffolded, fused or automatically associated into 
supramolecular structures through interactions between affinity domains and 
corresponding ligands.3,10-13 From the study discussed in Chapter 4, we have realized that 
polymeric co-immobilization of multiple enzymes is quite limited in directing their spatial 
organization. On the other hand, protein engineering provides a wide range of options for 
creating a “smarter” system in which the enzyme association is guided with controllable 
order, stoichiometry or structure orientation and improved robustness.
Another longstanding goal of engineered multienzyme assembly goes to facilitated 
mass transport, which makes the artificial system a real metabolon. For this purpose,
considerable efforts have been devoted to realizing natural occurrence in vitro by 
mimicking the native metabolic organization. In other words, this requires the knowledge 
of protein-protein interactions in native states, including the three-dimensional complex 
structure, interfacial residues or domains and possible conformational changes upon 
association.
Among already mentioned methods, posttranslational, selective enzyme 
conjugation turns out to be the most appealing method.14 In this case, modified enzymes 
can be separately expressed and undergo directed association in vitro. Site-specific 
incorporation of nonnatural amino acids functionalized with photoreactive moieties 
enables selective and orthogonal conjugation under light irradiation.5 UV-irradiated cross­
linking can be similarly carried out between a benzophenone-tagged protein and a 
transglutaminase recognition sequence-fused protein.15 Due to uniqueness in chemical 
reactivity and sequence location, N- and C-terminus have stood out as extraordinary targets 
in single-site modification by either chemical reagents or genetic fusion, and many elegant 
multienzyme systems featuring substrate channeling have been achieved from terminal- 
directed association.16-20
5.1.2 Structure-Based Design of the mMDH-CS Metabolon
As part of the TCA cycle metabolon, mMDH and CS can associate dynamically in 
even dilute solution. However, this interaction might proceed in a random manner. To 
reconstruct the mMDH-CS metabolon in vitro, we would need to place some restrictions 
on protein-protein interactions, so that they can form desired products. Finally, we chose 
to introduce two different peptide tags to the N- and C-terminus of each enzyme. The 
FLAG-tag fused to N-terminus is a hydrophilic, eight-amino acid peptide (DYKDDDDK),
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which selectively binds the monoclonal antibodies M1, M2 and M5. The hex His-tag fused 
to C-terminus is a short affinity tag consisting of six histidines (HHHHHH). Since the 
histidine imidazole ring can coordinate firmly to transition metal ions (Ni2+, Co2+, Cu2+, 
and Zn2+), polyhistidine-tagged proteins can be tethered to a transition metal-modified 
matrix.10
According to the three-dimensional structure of the natural TCA cycle metabolon 
derived from XL-MS and protein docking, N- and C-terminus of CS and C-terminus of 
mMDH are not buried in but positioned around the mMDH-CS interface. The other two 
N-terminus of mMDH point almost perpendicularly to the interface towards the opposite 
direction. Inspired by this conformation, we adopted the terminal-tagging strategy 
primarily based on the hypothesis that extended peptide tags on all terminus in this case 
would not interfere with intended interface formation but limit unwanted interactions at 
other surface regions, as surface complementarity is altered. Secondly, affinity tags on 
terminus would not deactivate enzymes as active sites are typically folded inside. The last 
but not the least, affinity peptide-tagged mMDH-CS complex can be used for oriented 
immobilization onto antibody- or transition metal-modified scaffolds or electrode surfaces 
in future development.
5.1.3 Stopped-Flow Method for Fast Enzyme Kinetics
Stopped-flow method refers to fast injection of a substrate solution and an enzyme 
solution into a small chamber or well, which is suddenly stopped after the desired volume 
is reached in a few miliseconds. Immediately upon stopping, detectors start to measure the 
product forming by UV-Vis absorbance or fluorescence emission change at very short time 
intervals. The stopping time may be varied to allow rate measurement at different reaction
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phases. Compared to conventional mixing by hand, stopped-flow is much more consistent 
in mixing time and sensitive to reduced small-volume (up to hundreds of microliters) 
reactions. Therefore, in study of fast enzyme kinetics, stopped-flow method is a powerful 
technique in determining short transient time at millisecond scale.21
5.1.4 Aims
To our knowledge, little work has been done so far on an artificial TCA cycle 
metabolon, except the fusion mMDH-CS complex made by the Srere group nearly 20 years 
ago.22,23 Besides hybridizing the two enzymes by fusing the termini together, now we may 
engineer a complex retaining the naturally occurring structure and featuring substrate 
channeling. In this work, we combined site-specific modification with XL-MS and protein 
docking again, and structurally evaluated the engineered mMDH-CS complex. 




Potassium phosphate was purchased from EMD chemicals. NAD+ was purchased 
from Research Products International. DSG was purchased from Life Technologies. All 
other chemicals were purchased from Sigma-Aldrich unless otherwise specified. WT heart 
mMDH, CS and aspartate aminotransferase (AAT) were purchased from Sigma-Aldrich in 
ammonium sulfate suspensions. WT heart ACO was purchased from Sigma-Aldrich as 
lyophilized powder. Recombinant heart mMDH, CS and ACO including site-directed 
mutated (nonterminal site) CS were synthesized and purified by Dr. Scott A. Banta and his 
colleagues. Ala-chitosan was prepared as already described in Section 4.2.2.
134
5.2.2 In Vitro Chemical Cross-Linking of mMDH and CS
WT and recombinant enzymes were cleaned up by a prepacked Sephadex™ G- 
25M column (GE Healthcare) to remove ammonium sulfate and other salts containing 
primary amine. Then mMDH, CS and ACO were mixed equally to a total protein 
concentration at 2 mg/mL in 10 mM PBS (pH 7.4). DSG (Life Technologies) dissolved in 
50 |iL of DMF was added to enzyme mixture to a final concentration of 1 mM. The 
approximate DSG/protein molar ratio was 50:1. As non-cross-linked control, 50 |iL of 
DMF containing no DSG was added. Cross-linking was incubated at room temperature for 
30 min under gentle shaking and quenched by adding 2 M Tris buffer (pH 8.3) to a final 
concentration of 20 mM.
5.2.3 Separation of the mMDH-CS Complex
Enzyme mixtures were washed with 50 mM Tris buffer (pH 7.4) in filter- 
incorporated Amicon tubes with a mass cutoff at 10 kDa (Millipore) at 5000 x g for 15 min 
to remove phosphates and extra DSG. Then cross-linked and non-cross-linked samples 
were directly separated by reducing SDS PAGE, which was performed on a 4-20% gradient 
gel (Thermo Scientific) according to the protocol provided by manufacturer.
5.2.4 Structural Determination of the mMDH-CS Complex and 
Simulation of Electrostatic Channeling
Identification of non-cross-linked and cross-linked peptides by in gel typsin 
digestion and mass spectrometry (including instrumentation and data analysis) was done 
as described in Section 3.2.5-3.2.8. Structure solving by hybrid protein docking was done 
as described in Section 3.2.9. Calculation of surface ESP was done as described in Section 
3.2.10 with pH set to 7.4.
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5.2.5 Competing Experiment with Aspartate Aminotransferase (AAT)
Equal amounts of WT/recombinant mMDH and CS were mixed in 10 mM PBS 
(pH 7.4) to a final total protein concentration of 20 ^M, and incubated under gentle shaking 
at room temperature for 30 min, followed by dilution to 4 |iM in same PBS buffer. Then 
100 |iL of the enzyme mixtures were mixed with 50 |iL of ala-chitosan (10 mg/mL), and 
incubated on vortex at 800 rpm for 15 min. To the bottom of each polystyrene cuvette, 25 
|iL of the enzyme-polymer suspension was drop-cast and let dry in a vacuum at room 
temperature for 2 h. Once dried, immobilized enzymes were assayed in a cocktail in 100 
mM potassium phosphate buffer (pH 7.4): 1 mM L-malate, 2 mM NAD+, 0.1 mM acetyl- 
CoA, 0.2 mM DTNB, 10 mM L-glutamate and 1 U/mL AAT. Absorbance at 412 nm was 
monitored every 1 s over 5 min.
5.2.6 Transient Time Measurement by Stopped-Flow Method
Stopped-flow experiment was carried out in a 96-well plate measured by a 
Synergy™ HTX multimode microplate reader (BioTek) equipped with a dual injection 
module. Before assays, 10 |iL of WT/recombinant mMDH (20 |iM) and 10 |iL of 
WT/recombinant CS (20 |iM) were mixed in 10 mM PBS (pH 7.4) and incubated under 
gentle shaking at room temperature for 30 min, followed by dilution to 2 mL in 100 mM 
potassium phosphate buffer (pH 7.4). In total three mixtures were prepared: WT mMDH- 
CS, recombinant mMDH-CS and recombinant mMDH-CS (Arg65 mutated to Ala65). No 
cross-linker was added during this step as to avoid any potential deactivation. Substrate 
solution was prepared in 2 mL of potassium phosphate buffer containing 2 mM L-malate, 
4 mM NAD+, 0.2 mM acetyl-CoA and 0.4 mM DTNB. To setup the assay condition, 
enzyme and substrate solutions were respectively injected by two separate syringes at a
flow rate of 250 |iL/s. Total assay volume was 200 |iL/s per well (light path length was 
0.56 cm). Absorbance at 412 nm was read every 90 ms over 1 min.
5.3 Results and Discussion
5.3.1 Formation of the mMDH-CS Complex In Vitro
In vitro cross-linking of mMDH-CS interactions was done together with ACO as 
to simulate the situation in the natural metabolon. As shown in Figure 5.1, intense protein 
bands appeared near the starting wells after cross-linking, indicating the formation of large 
aggregates, in which mMDH, CS and ACO were all identified by mass spectrometry. In 
mitochondria, cross-linking of all the TCA cycle enzymes in situ generated a huge complex. 
Being different in solution, the three enzymes would have more freedom to assemble into 
higher-ordered complexes, which might be the association of enzyme oligomers, or the 
aggregation of mMDH-CS-ACO complexes.
5.3.2 Structural Comparison of WT/Recombinant mMDH-CS 
Complexes to the Natural Metabolon
As previously mentioned, interactions between WT mMDH and CS in dilute 
solution can occur at random regions, which are shown in Figure 5.2. A number of docked 
models were found to meet our selection criteria (detailed in Section 3.2.9). Each model 
exhibited quite distinct conformation orientation and interface from the others. Among 
them, one candidate (highlighted in the red square) showed up as the most promising 
structure. In the case o f recombinant enzymes, protein-protein interactions appeared 
relatively simple. According to mass spectrometric identification and protein docking, only 
one structure was found and its conformation orientation looked very similar to that o f the 
natural metabolon. A structural comparison is illustrated in Figure 5.3. In the WT complex,
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Figure 5.1 Reducing SDS-PAGE of cross-linked and native (non-cross-linked) mMDH- 
CS-ACO complex in vitro. Bands in red squares were cut for digestion and mass 
spectrometric analysis: (A) cross-linked large WT mMDH-CS-ACO complex, (B) native 
WT mMDH subunit, (C) native WT CS subunit, (D) native WT ACO, (E) cross-linked 
large recombinant mMDH-CS-ACO complex, (F) native recombinant mMDH subunit, (G) 
native recombinant CS subunit, (H) native recombinant ACO.
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Figure 5.2 List of all possible docked structures for the WT mMDH-CS complex. The two 
chains of CS are colored in goldenrod and khaki. The two chains of mMDH are colored in 
sky blue and cyan. The most promising structure is highlighted by the red square.
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Figure 5.3 Docked structures of the natural TCA cycle metabolon (A), in vitro WT mMDH- 
CS complex (B) and recombinant mMDH-CS complex (C). N-terminus are represented by 
red spheres. C-terminus are represented by blue spheres. FLAG-tags are represented by red 
sticks. HexHis-tags are represented by blue sticks.
mMDH was flipped by approximately 180 degrees around the axis parallel to the original 
interface in natural metabolon, and consequently its two N-terminus were buried between 
enzymes. Meanwhile, all the other terminus went away from the interface. This flipping 
might be unfavorable for directed OAA transport, because the clefts between two subunits 
where L-malate and OAA are accommodated were now open to the bulk solution. The 
average distance between active sites was also increased from 35 A in the natural 
metabolon to 73 A.
In contrast to the WT complex, the recombinant complex exhibited some rational 
behavior in dilute solution. Although mMDH rotated around the axis perpendicular to the 
interface by approximately 30 degrees, the final structure maintained most of the natural 
features. First of all, no terminus were buried in the interface due to the spatial hindrance 
from additional tags at surface. Secondly, relative locations of terminus around the 
interface were not significantly altered. Thirdly, the two tagged N-terminus of mMDH 
were still extending into the open space. More importantly, the active site clefts in mMDH 
were facing towards CS not the bulk solution, and the average distance between active sites 
was only 40 A. It is worth mentioning that the interface area in the recombinant mMDH- 
CS complex was 12100 A2, suggesting that it may be more thermodynamically stable than 
either the natural metabolon (10000 A2) or the WT complex (11300 A2).
5.3.3 Proof of Enhanced OAA Channeling in the Recombinant 
mMDH-CS Complex
Slightly different from the simulation for natural metabolon at pH 7.8, the pH value 
used for calculation of surface ESP of the mMDH-CS complex in solution was set at 7.4, 
which was the medium pH. As depicted in Figure 5.4, positively charged continuous bands
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Figure 5.4 Simulated electrostatic channeling in the WT (A), recombinant (B) and arginine- 
mutated (C) mMDH-CS complex. Calculation of surface ESP was done at pH 7.4. Active 
sites are denoted by orange arrows and electrostatic channels are highlighted by yellow 
edges. Negatively charged, positively charged and neutral regions are colored in red, blue 
and white.
formed across the binding interfaces in both WT and recombinant complexes. In the WT 
complex, the band was quite long and broad with the majority of one side surface covered. 
Although flipping of mMDH increased the distance between active sites, OAA channeling 
may still happen within the positively charged pathway. In the recombinant complex, the 
band area was significantly smaller, only encompassing the active site clefts and binding 
interface. This is definitely favored by the restricted orientation of tagged enzymes. With 
a shorter channeling length, transport of OAA in the recombinant mMDH-CS complex 
would be faster than in the WT complex.
To prove the simulated kinetic advantage in the engineered metabolon, competing 
experiment was done in the presence of AAT, which catalyzes the reversible conversion of 
OAA and L-glutamate to aspartate and a-ketoglutarate. As illustrated in Figure 5.5, in a 
free-floating system, OAA diffusing into the bulk phase will be captured by AAT, thus 
resulting in reduced coupled mMDH-CS activity and production of citrate. If OAA is 
directly channeled, the coupled catalysis will not be influenced by the presence of AAT. In 
this work, ala-chitosan was utilized to localize the mMDH-CS complex and avoid the 
probable interactions between mMDH and AAT. For the WT complex, coupled activity 
decreased by about 30% after 1 U/mL of AAT was added, but for the recombinant complex, 
it only decreased by 15%, showing that the transport of OAA was less affected by the 
competitive enzyme (Figure 5.6). However, it should be noted that even in the engineered 
complex, substrate channeling was not perfect in preventing leaking of intermediates. This 
might be inevitable in dynamic metabolons, since the intermediate has to dissociate from 
enzymes. Potential interactions between mMDH and AAT could not be completely ruled 




























Figure 5.6 Coupled reaction rate of the immobilized mMDH-CS complex in the presence
of AAT.
at metabolon surface.
Another experimental evidence of substrate channeling was achieved from the 
measurement of transient time of OAA in coupled reactions by stopped-flow method, and 
the absorbance change within the first five seconds upon mixing of substrates and enzymes 
is shown in Figure 5.7. As discussed in Chapter 1, the coupled activity is in direct 
proportion to the rate of the transient process between intermediate release and rebinding. 
One important factor in determining the rate of this transient process is the surface distance 
between two active sites, which increased by roughly 35% in the recombinant complex 
compared to the WT complex. Shortened traveling distance undoubtedly facilitated an 
efficient coupling of the two enzymes. If the process was similar to a surface random walk, 
the theoretical time needed for intermediate diffusion would reduce by 70% in the 
engineered complex. However, experimental results show that, t  of the WT complex was 
around 293 ± 35 ms, and after terminal modification, t  was drastically reduced by 90% to 
30 ± 11 ms, implying that actual transport of OAA at complex surface was in a directed 
manner. It is also noteworthy that the relative orientation of active sites in the WT complex 
gives a higher chance of escaping of OAA into the bulk phase once released from mMDH.
As a negative control to the recombinant complex, disrupted channeling was 
achieved by replacing key residues contributing to rearrangement of electrostatic potentials. 
First we calculated the surface ESP after replacing the positively charged arginines on CS 
by neutral alanine. Simulation results (Figure 5.4) showed that the electrostatic connection 
of active sites was completely broken apart, and the surface ESP of the whole complex 
became more positive upon neutralization of the following CS arginines: 65, 67, 229, 324, 
329 and 334. To experimentally demonstrate site-directed mutagenesis-induced channeling
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Figure 5.7 Change of product absorbance at 412 nm over time (dots) in coupled enzymatic 
reactions from L-malate to citrate. Straight solid lines were drawn at the steady state phase 
where maximum production rate was achieved, and extrapolated to the time axis. Intervals 
denoted by arrows were the transient time ( t )  for each mMDH-CS complex.
disruption, we finally substituted CS Arg65 by Ala65. As shown in Figure 5.7, the coupled 
reaction rate drastically decreased with the transient time increased to nearly 1 s. The huge 
decline in catalytic performance of recombinant mMDH-CS complex indicated the crucial 
role of CS Arg65 in the metabolon formation, and also demonstrated that intermediate 
transport through channeling is enhanced by both the close proximity and a favorable 
conformation.
5.4 Conclusions
In this chapter, we have reconstituted an artificial TCA cycle metabolon in solution 
with recombinant mMDH and CS, and revealed that peptide-tagged N- and C-terminus in 
this specific situation can help orient protein-protein interactions in a more restricted 
manner. The resultant structure also shows its feasibility in oriented assembly. Simulation 
and kinetic study have demonstrated a significantly enhanced OAA channeling in the 
engineered metabolon compared to the WT mMDH-CS complex. In alanine scanning, CS 
Arg65 turns out to be a key residue in formation of metabolon and substrate channeling. 
Although the results we have obtained so far are preliminary, they at least point out a 
direction that we can follow in fabricating a metabolon mimic in vitro. This is the first 
attempt of making an extracellular TCA cycle metabolon based on naturally formed 
structure in combination of mass spectrometry, computer simulation and protein 
engineering. Ongoing efforts in the near future will be devoted to mapping of dominant 
residues in channeling construction by site-directed mutagenesis, which will also give us 
some deeper insight into the nature of the TCA cycle metabolon.
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CHAPTER 6
SUMMARY AND FUTURE WORK
6.1 Summary
6.1.1 Mechanism for the TCA Cycle Metabolon Formation
The TCA cycle, consisting of eight enzymatic reactions, plays an essential part in 
complete oxidation of metabolites and generation of reducing power for ATP production 
in the cell.1 Sequential enzymes in the TCA cycle are weakly associated into a 
supramolecular complex which is the TCA cycle metabolon.2 Metabolons are known for 
featuring efficient intermediate transport or substrate channeling, and compartmentalizing 
metabolites into small, discrete pools, generating concentration gradients throughout the 
mitochondrial matrix.3 However, the driving force for metabolon formation is still unclear, 
and the potential role played by these intermediate pools in metabolic organization has not 
been systematically explored.
A Y-shaped microfluidic channel was fabricated to examine transport of mMDH 
and CS in response to different substrate concentrations. It shows that each enzyme 
diffused against the concentration gradient of its specific substrate, and the apparent 
diffusivity was increased at higher substrate concentration. A following study on double 
enzymes demonstrates an enhanced co-diffusion against the concentration gradient of L- 
malate in the presence of coupled catalysis, indicating an OAA-induced “attraction” 
between mMDH and CS. Possible mechanisms were explored by removing cofactors or
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adding inhibitors, and significant decline in either apparent diffusivity of a single enzyme 
or co-diffusion of coupled enzymes was observed. Results suggest that directed enzyme 
transport stimulated by a substrate concentration gradient is mainly driven by the 
conformational alteration upon ligand binding and can be accelerated by transition cycles 
during complete catalysis. This work finally reveals the driving force on dynamic 
association in the TCA cycle metabolon exerted by intermediate gradients between 
sequential enzymes.
6.1.2 Structure of the Natural TCA Cycle Metabolon
It is believed that high metabolic flux through the TCA cycle is facilitated by 
electrostatic channeling in the metabolon.2,4 To prove its existence and advantage, fusion 
protein of mMDH/CS was studied by Srere et al. and they were able to simulate the 
electrostatic channeling formed between active sites in the fusion protein. Despite their 
work, there is little knowledge of protein-protein interactions between the TCA cycle 
enzymes inside mitochondria. Structural insights are needed for better understanding of 
natural occurrence in the metabolon.
In vivo chemical cross-linking was performed in intact mitochondria and fixed 
metabolons were analyzed by mass spectrometry for constituent enzymes and conjugated 
peptide fragments. Using a hybrid protein docking method, we finally resolved the 
structure of the mMDH-CS-ACO complex as a part of the giant metabolon. In this structure, 
mMDH, CS and ACO are associated asymmetrically, and their active sites are separated 
by short distances. Another noteworthy fact is that no terminus participate directly in 
binding, but they may play nontrivial roles in determining the final structure. Simulation 
of surface ESP reveals a charge rearrangement upon protein-protein interactions that leads
to the formation of a continuous surface band of positive potential, which may facilitate 
direct channeling of anionic intermediates between active sites.
6.1.3 Fabrication of the Artificial TCA Cycle Metabolon
Diverse efforts have been made to fabricate multi-enzyme assemblies featuring 
ordered organization and substrate channeling.5 In general, there are two goals to pursue in 
making a metabolon mimic. One is the close proximity between enzymes, and the other is 
oriented assembly favoring substrate channeling. When pursuing these goals, one needs to 
address two questions. What tools may be used to keep enzymes together? What structure 
should the biomimic achieve? Finding out the answers will undoubtedly lead to a satisfying 
system.
One strategy investigated in this dissertation is polymeric co-immobilization. 
Model enzymes, mMDH, CS and ACO, were co-immobilized into LPEI, Nafion and 
chitosan polymers. Their interactions affected by polymer properties were characterized 
by FRET microscopy in terms of interprotein distances. On one hand, the result proves that 
multienzyme aggregation can be enhanced upon hydrophobic modifications, especially in 
polymers bearing micellar structures. As it suggests, trimethyloctadecylammonium 
modified Nafion is the best platform, in which co-immobilized enzymes have the shortest 
separation, highest single enzyme activity and most uniform localization. On the other hand, 
this study reveals that polymeric co-immobilization is not a rational technique in making 
real metabolons. Even though enzymes can be confined within short distances, their 
relative orientation is not manageable and self-aggregation may occur.
As another advanced alternative to polymeric co-immobilization, protein 
engineering was exploited, and N- and C-terminus of mMDH and CS were modified by
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FLAG-tag and hexHis-tag, respectively. According to our knowledge of mMDH-CS 
interaction in the natural TCA cycle metabolon, we assumed that extended peptide tags 
would restrict the random binding in solution and only facilitate the orientation observed 
in vivo. Mass spectrometric and protein docking results validate our hypothesis, showing 
that interactions between peptide-tagged enzymes were directed to form a unique structure 
mimicking natural complex. This structure-based design proves it as a success in making 
a real metabolon in vitro, not only because the naturally occurring structure was retained, 
but also because o f highly efficient intermediate transport, which is demonstrated by 
surface ESP simulation and kinetic studies.
6.2 Future Work
6.2.1 Future Directions
This research is ultimately aimed at reconstituting a robust enzyme cascade to 
mimic the function of the TCA cycle metabolon, which can be applied on the bioanode in 
a high-performance enzymatic BFC. The bioelectrocatalyst is able to catalyze complete 
oxidation of biofuels at fast turnover rate and high mass transport efficiency. Basically two 
directions can be followed: naturally occurring metabolons and artificial metabolon mimics. 
Proteins have evolved to acquire most favorable shape complementarity and recognition 
sites to allow their efficient incorporation in metabolism.6,7 Therefore, direct utilization of 
the natural TCA cycle metabolon is a straightforward way of taking advantage of this in 
bioelectrocatalysis, provided that it is isolatable and robust. Artificial TCA cycle 
metabolon mimic can be fabricated with purified, engineered enzymes and is more 
compatible with different immobilization techniques. Further attempts should be made to
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grouping the TCA cycle with other upstream enzymes or metabolic pathways and 
broadening the range of usable fuels for BFCs.
6.2.2 Isolatable Natural TCA Cycle Metabolon
As an amelioration of the in vivo chemical cross-linking discussed in Chapter 3, the 
TCA cycle metabolon is fixed by photoreactive nonnatural amino acids, which are 
incorporated into the protein primary sequence by cellular synthesis machinery. 
Commonly employed photoreactive amino acids are diazirine analogs of 
leucine/methionine and benzoylphenylalanine. After incorporation, exposing cell lines or 
intact mitochondria to ultraviolet light activates cross-linking of interacting enzymes in 
native environment. Since photoreactive non-natural amino acids behave just as their 
natural counterparts and can be incorporated at specific sites, extensive or random cross­
linking causing metabolon distortion or deactivation is avoided.8 Using this strategy, we 
can obtain robust TCA cycle metabolon without affecting its structure and activity through 
routine protein purification procedures.
6.2.3 Self-Assembled TCA Cycle Metabolon In Vitro
Study of enzyme dynamics in metabolon formation stimulated by intermediate 
generation provides a possibility of self-assembly in solution driven by catalysis. As 
previously reported by Sengupta et al., immobilized enzymes can function as self-powered 
micropumps which drive directed transport of nanoparticles.9 In fact, we can extend it to 
coupled enzymes and start sequential assembly simply by orderly adding substrates and 
following enzymes. To achieve this, an anchoring enzyme needs to be tethered to a surface 
or scaffold. For the TCA cycle metabolon, aKGDH complex turns out to be the best 
anchoring enzyme due to its large size. Affinity tags such as His-tags may be used to form
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a protein monolayer on a modified electrode surface, or coordinate the enzyme into a three­
dimensional polymer, protein or DNA scaffold. Alternatively, SDH can also anchor the 
rest of the TCA cycle enzymes to a lipid bilayer on the electrode, which actually simulates 
the occurrence in mitochondria.10,11 Once catalysis is started in the presence of cross­
linkers, intermediate-linked enzyme association will be fixed in situ.
6.2.4 Rational Engineering of Artificial Metabolon Mimics
Investigation of the natural TCA cycle metabolon is continued to resolve 
subsequent protein-protein interactions. Using structural information, we can design 
recombinant enzymes modified by functional groups or affinity tags at specific sites. These 
sites could be interfacial residues or residues located around the interface to enable directed 
association of free enzymes in vitro. However, deriving the three-dimensional structure of 
the whole metabolon needs extensive work and numerous mutation sites may be tried until 
the desired complex is attained. Another strategy is DNA scaffold-mediated assembly, by 
which recombinant TCA cycle enzymes are tethered to a linear DNA strand or a closed 
circle in an ordered manner. In this situation, orientation and stoichiometry are controllable, 
and intermediates are channeled from one site to the next.
6.2.5 Combining the TCA Cycle and Other Metabolic Pathways
As previously summarized in Figure 1.1, the TCA cycle serves as the endpoint of 
the complete oxidation of a variety of carbohydrates, fatty acids and amino acids.12 In 
principle, coupling the TCA cycle to other metabolic pathways, such as glycolysis, P- 
oxidation of fatty acids/lipids and transamination, expands the potential fuel sources of 
high energy densities and improves power output of a BFC. For example, complete 
oxidation of one glucose molecule by glycolysis pathway-the TCA cycle gives 24 electrons.
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Combining p-oxidation and the TCA cycle, complete oxidation of one steric acid molecule 
generates 52 electrons.12 Amino acids give fewer electrons per molecule via 
transamination-the TCA cycle, but their abundance in proteins makes them promising 
energy sources for BFCs powered by degraded proteins. Further efforts shall be made in 
simplifying the catalytic pathways with synthetic oxidoreductases to improve the stability 
and catalyst loading on the electrode.
6.3 End Remarks
This dissertation work has elucidated the protein-protein interactions in the TCA 
cycle metabolon from mechanistic and structural perspectives, which helps the 
understanding of its nature as an efficient biocatalyst. Continuation of fundamental work 
will be in-depth exploration of enzyme cooperativity in metabolon formation and substrate 
channeling with the aid of protein engineering. Before moving on to a practical 
bioelectrocatalyst, metabolic regulation of the TCA cycle and its effectors in vitro should 
also be thoroughly characterized on the electrode. All these efforts ultimately leads to a 
promising future in the realm of portable micro-power sources with improved energy, 
current and power densities.
6.4 References
(1) Nunes-Nesi, A.; Araujo, W. L.; Obata, T.; Fernie, A. R. Curr. Opin. Plant. 
Biol. 2013, 16, 335.
(2) Robinson, J. B. J.; Inman, L.; Sumegi, B.; Srere, P. A. J. Biol. Chem.
1986, 262, 1786.
(3) Oaks, A.; Bidwell, R. G. S. Annue. Rev. Plant. Physiol. 1970, 21, 43.




(5) Schoffelen, S.; van Hest, J. C. M. Soft Matter 2012, 8, 1736.
(6) Lai, Y. T.; King, N. P.; Yeates, T. O. Trends. Cell. Biol. 2012, 22, 653.
(7) Moreira, I. S.; Fernandes, P. A.; Ramos, M. J. Proteins 2007, 68, 803.
(8) Gomez-Nunez, M.; Haro, K. J.; Dao, T.; Chau, D.; Won, A.; Escobar- 
Alvarez, S.; Zakhaleva, V.; Korontsvit, T.; Gin, A. Y.; Scheinberg, D. A. PLoS One 
2008, 3, e3938.
(9) Sengupta, S.; Patra, D.; Ortiz-Rivera, I.; Agrawal, A.; Shklyaev, S.; Dey, 
K. K.; Cordova-Figueroa, U.; Mallouk, T. E.; Sen, A. Nat. Chem. 2014, 6, 415.
(10) D'Souza, S. F.; Srere, P. A. J. Biol. Chem. 1983, 258, 4706.
(11) Lyubarev, A. E.; Kurganov, B. I. BioSystems 1989, 22, 91.
(12) Bohinski, R. C. In Modern Concepts in Biochemistry; 5th ed.; Allyn and 
Bacon, Inc.: Newton, 1987, p 540.
